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ABSTRACT OF THESIS 
THE BIOLOGICAL AND PHYSIOLOGICAL EFFECTS OF EXCESS COPPER IN 
JUVENILE MALLARDS (Anus platyrhynchos): AN INVESTIGATION OF THE 
TOXICITY OF ACID MINE DRAINAGE. 
In the early 1990's, concentrations of copper in the Alamosa River were increased by 
the release of acid mine drainage from the Summitville Mine site. Concern about the 
potential impact to resident waterfowl led to an investigation of copper toxicity in 
juvenile mallards. The investigation described in this thesis included a small field survey 
and six laboratory studies. The field survey provided an indication of potential exposure 
concentrations and a relative measurement of copper exposures in mallards from the 
Alamosa River. The laboratory studies examined the biological and physiological effects 
of excess copper in juvenile mallards and the relationship between copper exposure and 
tissue copper accumulation. 
Acute copper toxicity produced mortality in juvenile mallards that received a drinking 
water dose of 800 milligrams of copper per kilogram body weight per day (mg Cu/kg 
BW/d). Sublethal copper toxicity was quantified by decreased weight gain. Mallards 
experienced minor reductions in weight gain (10-20%) with exposures ranging from 70-
210 mg Cu/kg BW/d. Weight gain was substantially decreased, by more than 50% 
compared with control birds, in mallards that received larger doses of copper(~ 250 mg 
Cu/kg BW/d). Based on decreased weight gain, a dose of 20 mg Cu/kg BW/d was 
111 
determined to be a No Observed Adverse Effect Level (NOAEL) for copper in juvenile 
mallards. 
Tissue copper concentrations were measured by flame atomic absorption spectro-
photometry. Untreated mallards accumulated substantial concentrations of copper in 
their livers, up to 700 µg Cu/g on a dry weight basis. Hepatic copper increased 
significantly in mallards that received a dose greater than or equal to 160 mg Cu/kg 
BW/d. 
Feather copper concentrations were significantly correlated with both dietary (R2 = 
0.99, p < 0.001) and drinking water exposure (R2 = 0.76, p < 0.001). Analysis of feather 
tissue was determined to be the most sensitive method for evaluating copper exposure. 
Feather copper concentrations were significantly increased in mallards that received a 
dose greater than or equal to 70 mg Cu/kg BW/d. 
Concentrations of copper in both liver and feather tissue reached their peak at a dose 
below the highest treatment level. Copper accumulation appears to be diminished in 
birds that received doses greater than or equal to 340 mg Cu/kg BW/d. 
Drinking water pH was investigated for its ability to influence copper absorption. 
Copper accumulation in feather tissue was significantly reduced when exposure pH was 
decreased. In addition to influencing tissue copper accumulation, acidic water (pH~ 3.5) 
produced signs of direct toxicity in juvenile mallards. Weight gain was significantly 
reduced in mallards exposed to drinking water at pH 3.5. Drinking water at pH 3.0 
exceeded the LC50 for very young mallards ( < 5 days old). 
IV 
Evaluation of liver tissue from mallards that were collected on the Alamosa River 
indicated that these birds had increased exposure when compared to mallards from 
uncontaminated areas. Vegetation collected from the Alamosa River below the 
Wightman Fork contained a substantial concentration of copper, 463 mg Cu/kg. A diet 
that consisted solely of this copper-rich vegetation would provide mallards with 
approximately 88 mg Cu/kg BW/d. A similar dose of copper significantly reduced 
weight gain in laboratory mallards. 
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CHAPTER 1 INTRODUCTION 
1.0 Purpose 
Copper (Cu) is a biologically important mineral and the twenty-fifth most abundant 
metal in the Earth's crust (Sidhu, 1995, and Demayo, 1982). Mining and other industrial 
activities have increased environmental copper concentrations in certain areas, producing 
elevated exposures for resident wildlife populations. Adequate dietary intake of copper is 
important, but excess copper can result in adverse health effects (Sidhu, 1995). This 
thesis describes the biological and physiological effects of excess copper in juvenile 
mallard ducks (Anas platyrhynchos). 
In 1986, the Summitville Mine Site in Southwestern Colorado began to release a 
substantial amount of copper into the Wightman Fork of the Alamosa River (King, 1995). 
The studies described in this thesis were conducted as part of a site investigation for the 
Summitville Mine Site, which was initiated by the U.S. Environmental Protection 
Agency (EPA) Region VIII and the Colorado Department of Public Health and 
Environment. These agencies wanted to evaluate the potential hazard of elevated copper 
concentrations in the Alamosa River to non-human terrestrial receptors. Waterfowl are 
among the classes of receptors that are potentially exposed to copper in this area. 
1 
1.1 Summitville Mine Site 
From 1985 through 1992, the Summitville Mine produced gold from low-grade ore 
using cyanide heap-leach techniques. The mine's operator had ceased active mining and 
initiated environmental remediation when it declared bankruptcy in December 1992. In 
May 1994, EPA placed the site on the National Priorities List. Environmental problems 
at Summitville included leakage of cyanide-bearing solutions and acidic metal-rich 
drainage into the Wightman Fork of the Alamosa River (King, 1995). Early remediation 
efforts included the control of leaking adits, construction of a water treatment facility for 
cyanide removal, back-filling and capping the open mine pit (King, 1995). Despite the 
efforts to contain the contamination, a substantial amount of copper was released into the 
Alamosa River between 1992-1995 (King, 1995). 
1.2 Waterfowl Habitat 
The Alamosa River flows from the San Juan Mountains into the San Luis Valley 
(Figure 1.1 ). The valley is a major migratory pathway for a number of avian species, 
including some threatened and endangered species. Representative of both state and 
federal agencies felt that the rich avian resources in this area supported the need to 
investigate the potential risk to waterfowl from increased copper in the Alamosa River. 
1.3 Study Design 
The primary objective for this investigation was to obtain data that could be used to 
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Figure 4.1 Map of the Alamosa River 
Wightman Fork. To achieve this goal, a field survey was conducted to evaluate potential 
exposure conditions on the Alamosa River. The lack of duck samples available from the 
field precluded a conclusion on the impact of excess copper in mallards. 
A series of laboratory studies were performed to define the toxicity of copper in 
juvenile mallards. Prior to this investigation there were very limited data on the toxicity 
of copper in mallards or any other species of waterfowl. Mallards were selected as a 
representative waterfowl species because there is breeding population of this species on 
the Alamosa River (Archuleta, 1995) and because their commercial availability facilitated 
laboratory investigations. This investigation focused on juvenile birds because they are 
potentially sensitive individuals and because pre-flight birds collected in the field have a 
definable exposure area and exposure period. 
1.3.1 Field Survey 
Early in the development of this project it was determined that it would not be feasible 
to conduct a series of controlled toxicity tests in the field. In the summer of 1995, 
juvenile mallards and environmental samples were collected from the Alamosa River for 
metals analysis. The objectives of field survey were to: 
1) Collect site specific information about potential sources of copper exposure. 
2) Compare the tissue copper concentration in juvenile mallards raised on the Alamosa 
River to birds from a reference area. 
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1.3.2 Laboratory Investigations 
The lack of substantial mallard populations available for sampling on the Alamosa 
River raised the question of whether this could be due to direct copper toxicity to the 
birds. Because of the lack of adequate literature data on copper toxicity, a series of six 
toxicity studies were conducted with juvenile mallards in order to provide data to support 
the interpretation of the results of the field study. There were two objectives for the 
laboratory studies: 
1) Determine safe and unsafe copper exposure in juvenile mallards. 
2) Develop methods for assessing copper exposure in wild birds. 
To achieve these goals, each of the laboratory studies was designed to collect a specific 
set of observations. The specific aims for the six studies were: 
Study One - Determine a minimum concentration of dietary copper that would produce 
signs of toxicity. 
Study Two - Compare the toxicity of dietary cupric acetate and cupric sulfate. 
Study Tltree - Determine a concentration of copper in drinking water that would produce 
signs of toxicity and investigate the. influence of pH on copper 
bioavailability. 
Study Four - Determine a minimum concentration of copper in drinking water that 
would produce signs of toxicity, and to investigate the influence of pH on 
copper tissue accumulation. 
Study Five - Evaluate the toxicity of copper and acidic pH water between previously 
observed levels of effect and no effect. 
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Study Six - Determine if prolonged exposure to low concentrations of copper in 
drinking water would produced signs of toxicity, or measurable increases 
in tissue copper concentrations. 
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CHAPTER 2 LITERATURE REVIEW 
2.0 Biological Role of Copper 
Copper is an essential nutrient required for a number of biological processes including: 
host defense mechanisms, red and white blood cell maturation, myocardial contraction, 
glucose and cholesterol metabolism (Olivares, 1996). Copper is also important for the 
synthesis of a number of enzymes including catalase, peroxidase, superoxide dismutase, 
and cytochrome oxidase (Goyer, 1996). Furthermore, copper is required for proper iron 
utilization and a deficiency of copper can result in anemia (Aiello, 1998). Copper 
supplementation is commonly used to increase production of several domestic species 
including swine and poultry (Cheeke, 1991). Recommended dietary copper levels vary 
among species: poultry 6 - 8 mg Cu/kg feed, horses and dairy cattle 10 mg Cu/kg feed, 
and swine 5 mg Cu/kg feed (Cheeke, 1991). 
2.1 Copper Metabolism 
2. 1. 1 Copper Absorption 
In most mammalian species, the majority of copper absorption takes place in the 
duodenum and jejunum (NAS, 1980), but some copper appears to be absorbed from the 
stomach (Cousins, 1985). The mechanisms of copper absorption are not completely 
understood (Underwood, 1971). It is thought that copper is transported across the brush 
border surface of the small intestine bound to one or more absorbable ligands (Cousins, 
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1985). Copper absorption is influenced by a number of factors including dietary 
composition, the animal's age, the form of copper, the route of exposure, and the 
presence of other minerals in the diet (ATSDR, 1990). Dietary levels of zinc, 
molybdenum, and sulfate are reported to have a significant effect on copper absorption in 
mammals (NAS, 1980). Competition with intestinal binding ligands appears to be one 
the factors that limit copper absorption (Cousins, 1985). 
2.1.2 Copper Binding Proteins 
Copper metabolism consists mainly of its transfer to and from various organic ligands 
including the sulfhydryl, and imidazole groups on amino acids and proteins (ATSDR, 
1990). Once copper is absorbed, cupric ions bind loosely to albumin (NAS, 1980). The 
albumin protein has a high affinity for binding copper on the N - terminus (Goode, 1988). 
Albumin facilitates the transport of copper to the liver where the majority of copper, 
approximately 90%, is thought to bind with the metalloprotein ceruloplasmin (Goode, 
1988). 
Ceruloplasmin is an acute phase protein whose synthesis is increased by acute 
inflammatory conditions such as bacterial or viral infections (Jain, 1993). There is 
conflicting evidence on the induction of ceruloplasmin with copper treatment (Cousins, 
1985). In the liver, copper attaches tightly to the 6 or 7 copper binding sites on 
ceruloplasmin and is then released into general circulation (NAS, 1980). The function of 
this protein in copper metabolism is not completely characterized, but it has been 
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suggested that dysfunction in ceruloplasmin synthesis may be associated with increased 
susceptibility to copper toxicity (Chowrimootoo, 1996). 
Metallothionein (MT) is a heat-stable metal binding protein. Synthesis of 
metallothionein is increased by exposure to a nwnber of metals including mercury, 
cadmiwn, and zinc (Y arnada, 1991 ). Metallothionein has a high affinity for binding 
copper, but copper is not considered a strong inducer of the metalloprotein (Eaton, 1980). 
However, because of its high affinity for copper, metallothionein is thought to play an 
important role in copper storage and distribution (Eaton, 1980). 
2.1.3 Distribution 
Sites of tissue copper accwnulation vary among species, but the liver, kidneys, brain, 
and heart consistently contain the highest concentrations of copper (Underwood, 1971). 
Liver copper concentrations normally range, on a dry matter basis, from 15 to 30 mg 
Cu/kg for a wide variety of monogastric mammals and domestic fowl (Beck, 1956). The 
liver copper concentrations in ducks, cattle, and sheep are generally 10 times greater than 
most other species (NAS, 1980). 
The preferential accwnulation of copper by the liver, appears to involve more than just 
having first access to absorbed copper in the portal circulation because this trend is 
observed with both oral and parenteral administration (Ettinger, 1986). Unfortunately, 
little is known about the copper uptake mechanism in hepatocytes. The process appears to 
follow first-order kinetics and utilize a passive carrier-mediated mechanism (Ettinger, 
1986, and Cousins, 1985). 
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Amino acids and albumin are the ligands which most likely present copper to the 
hepatocytes for transport across the plasma membrane (Cousins, 1985). Regardless of 
the mechanisms for copper uptake, in most species the liver is the primary storage organ 
and analysis of liver copper can often provide a reasonably reliable index of an animal's 
copper status (Underwood, 1971). 
2.1.4 Excretion 
The biliary system is the major excretory pathway for copper, but small quantities 
appear to be excreted directly into the intestine (NAS 1980). It has been suggested that 
ceruloplasmin may play an important role in regulating copper excretion (Chowrimootoo, 
1996). 
2.2 Copper Toxicity 
Acute or chronic copper poisoning can occur when excess amounts of copper are 
ingested. Acute copper poisoning in non-avian species typically presents as severe 
gastroenteritis characterized by abdominal pain, diarrhea, anorexia, dehydration, and 
shock (Aiello, 1998). Copper appears to be corrosive to mucous membranes of the 
gastrointestinal tract (Nicholson, 1995). Chronic copper toxicosis is usually subclinical 
until the hepatic storage capacity is exceeded and then copper is released into the blood 
stream in massive amounts (Demayo, 1982). A hemolytic crisis, caused by the 
destruction of red blood cells, is commonly associated with the release of free copper 
from the liver (Demayo, 1982). There is a marked difference among species in their 
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ability to tolerate excess dietary copper levels. Dietary levels that are toxic to ruminants 
are well tolerated by non-ruminants (Underwood, 1971 ). Continued dietary exposure to 
10 mg Cu/kg feed will produce toxicity in sheep (Cheeke, 1991). Patterns of hepatic 
copper storage vary among species; liver copper concentrations in sheep increase in 
proportion to their dietary intake, while rats maintain normal liver copper levels until a 
high dietary level is reached (Underwood, 1971). 
Several disease conditions are associated with impaired copper regulation. A classic 
example is Wilson's disease, an inborn error of copper metabolism that affects humans. 
Wilson's disease is characterized by excessive accumulation of copper in the liver, 
kidney, brain, and cornea (Sarkar, 1983). The biochemical defect produced by this 
genetic disease is not known. However, it is has been suggested that an alteration in the 
copper excretion pathways may be the responsible for this condition (Chowrimootoo, 
1996). A disease similar to Wilson's disease is found in the Bedlington Terrier (Aiello, 
1998), suggesting that genetic predisposition to copper toxicity may exist in non-human 
species. 
2.2.1 Copper Toxicity in Avian Species 
Symptoms of copper toxicity in avian species include listlessness, ruffled feathers, 
drooping head, variable appetite, voiding of bluish-green seromucous urates, watery 
diarrhea, and weight loss (Pullar, 1940 and Aiello, 1998). Pathological lesions associated 
with copper toxicity have been found in the oral cavity, gizzard, proventriculus, 
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gastrointestinal tract, and liver (Jensen, 1991, Henderson, 1975, and Pullar, 1940). 
Reported lesions include burns or erosion in the lining of the gizzard, catarrhal 
gastroenteritis, and hemosiderin (Aiello, 1998, Goldberg, 1956). 
Copper is widely used as a dietary supplement to increase weight gain in weight gain 
(Underwood, 1 971). It has been reported that 10 - 100 mg Cu/kg feed can increase 
weight gain in chickens and turkeys (Christmas, 1981, and Waibel, 1963). Because of the 
potential economic benefit associated with increased weight gain, the poultry industry has 
investigated the affects of copper in several domestic avian species. 
A 10 week dietary study conducted with chicks found that 570 mg Cu/kg in feed 
reduced weight gain by approximately 10% (Mehring, 1960). Turkey poults that received 
feed with 800 mg Cu/kg for 3 weeks experienced a 10% reduction in weight gain 
(Waibel, 1963). The survival rate in chicks was significantly reduced by greater than 
40% after 10 weeks of exposure to 1,150 mg Cu/kg (Mehring, 1960). 
The threshold of copper toxicity in avian species appears to be influenced by a number 
of factors including species, the form of copper, and dietary composition (Demayo, 
1982). It has been reported that copper toxicity was significantly increased in turkey 
poults by changing their diet from a natural diet to a purified diet (Waibel, 1963). 
Conversely the addition of excess zinc to the diet has been demonstrated to decrease 
copper toxicity in turkey poults (Supplee, 1964). 
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2.2.2 Copper Toxicity in Waterfowl 
Prior to this investigation there were limited data available on the toxicity of copper in 
waterfowl. An extensive literature search found one study on the toxicity of copper in 
ducks. Pullar reported that mallards which received gavage doses greater than or equal to 
55 mg of copper carbonate per kg body weight per day (mg/kg BW/d) for 26 days 
experienced reduced weight gain and mortality (1940). This same author also found that 
a single gavage dose of 400 mg copper sulfate produced acute copper poisoning in adult 
mallards (Pullar, 1940). Pullar administered copper to several avian species, and found 
that ducks were more sensitive to copper treatment than either pigeons or chickens 
(1940). The dose of copper sulfate required to produce mortality in mallards was 400 mg 
per kg body weight (mg/kg BW) compared to 1500 mg for pigeons, and 3000 mg/kg BW 
for fowl (Pullar, 1940). 
Several reports have documented copper treatment in ducks without adverse effects. 
Aylesbury ducklings provided with a diet that contained 100 mg/kg copper sulfate 
demonstrated increased growth and no signs of toxicity (King, 1975). Rowe and Prince 
offered adult mallards a choice between water with 100 mg/L copper sulfate or untreated 
drinking water and found that the birds preferred the copper - treated water; no health 
effects were reported (1983). 
There are only a few recorded incidences of copper toxicity in waterfowl following 
environmental exposure. In one case, a group of 100 Canada geese were found dead 
following exposure to water that contained 600 mg/L copper sulfate (Henderson, 1974). 
These birds had extensive necrosis of the upper digestive tract and liver copper 
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concentration ranging from 56-97 mg/kg wet weight (WW); estimated as 204 - 353 
mg/kg dry weight (DW) assuming a 72% moisture content. 
Eight mute swans were found dead in a Japanese river that was thought to be 
contaminated with copper (no environmental data were provided). The mean liver copp~r 
concentration for these birds was 2150 ± 2280 mg Cu/kg DW (mean ± standard 
deviation) (Kobayashi, 1992). Pathological findings in these birds included focal 
necrosis of the liver and hepatic lipofuscin. Another study compared liver copper 
concentrations in mute swans collected from a contaminated lagoon in Denmark to birds 
from non-industrial areas (Clausen, 1978). Swans from the industrial area had a mean 
liver copper concentration of 1096 mg/kg (N = 32) and birds from the reference areas had 
a mean liver copper concentration of 391 mg/kg in (N = 15) one site and 418 mg/kg in 
another (N = 44). 
2.3 Literature Values 
2.3.1 Reported Concentrations of Copper in Waterfowl Tissues 
Analysis of contaminant concentrations in tissues is a standard method for evaluating 
physiological uptake and biological accumulation. For many contaminants, including 
copper, the liver is the principle site of accumulation (Underwood, 1971). It has been 
reported that compared to other animals, ducks have relatively high levels of copper in 
their livers (Beck, 1956). Liver copper concentrations for turkeys and chickens typically 
range from 12.7 - 17.0 mg/kg on a dry weight (DW) basis (Beck, 1956). The reported 
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mean liver copper concentration for group of Muscovy ducks (N = 34) was 153 ± 21 
mg/kg DW (Beck, 1956). 
Table 2.1 summarizes the wide range of liver copper concentrations that have been 
reported for adult mallards. There is a clear difference between the liver copper 
concentrations for mallards that were raised in laboratories and those that were collected 
from the field. It seems likely that the increased hepatic copper concentrations in 
laboratory-raised ducks are the result of dietary differences. However, it should be noted 
that the reported copper concentration for the commercial feed used in the laboratory 
studies conducted by Di Giulio et al. was only 7 mg Cu/kg (1984a,b). 
Table 2.1 Reported Liver Copper Concentrations in Adult Mallard Ducks 
Source N Liver Cu (µgig DW) Reference 
Field 15 35 Chupp (1964) 
Field 157 52 Di Guilio et al. (1984a) 
Field 8 61 ± 52 a Archuleta ( 1992) 
Unknown 34 153 ± 21 Beck (1956) 
Laboratory controls 12 332 ± 84 Di Guilio et al. (1984a) 
Laboratory controls 8 585 ± 133 Di Guilio et al. (1984b) 
a Mean ± standard deviation 
Metal concentrations in feathers have been used as a method for associating breeding 
populations with specific geographic areas (Ranta, 1978) and for evaluating metal 
contamination (Rose, 1982, Parker, 1985). Metal concentrations in feathers are thought 
to reflect dietary intake because metals are incorporated into feathers during growth 
(Parker, 1985). 
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Mallard feathers (N = 47) collected from an uncontaminated site in Ontario, Canada, had 
copper concentrations ranging from O - 23 µg Cu/g (Ranta, 1978). 
2.3.2 Body Weight and Food Consumption 
Body weights for mallards at various ages are available in the published literature, 
there is a general consensus that males weight more than females and that body weight at 
fledging is approximately 75% the weight of adult birds (EPA, 1993). Feed consumption 
is reported in a number of published studies, but water consumption is generally 
estimated with an allometric equation (EPA, 1993). Table 2.2 summarizes the data 
available in the literature for body weights and feed and water consumption values for 
mallard ducks. 
Table 2.2 Reported Mallard Feed and Water Consumption Rates 
Reference Body weight Feed Feed Water 
Di Giulio (1984c) 




(g) (g/d) (gig BW/d) (g/d) 
1116 ± 36 105 ± 8 0.094 NA 
1201 ± 46 137 ± 13 0.114 NA 
1043 a NA NA 60 
1225 b NA NA 67 
NA NA NA 157±28 
Reported as mean ± standard deviation 
a adult female, 740 at fledging (56 days). 









2.3.3 Clinical Chemistry/Hematology Parameters 
Clinical chemistry and hematology panels are standard diagnostic techniques. Changes 
in enzymes, ions, and cell types can provide an indication of an organism's physiological 
status. In many species, copper toxicity presents with signs of liver damage and 
hemolytic anemia (Aiello, 1998). Hepatocyte damage can be detected by elevated 
concentrations of glutamate dehydrogenase, sorbitol dehydrogenase and aspartate 
aminotransferase (AST) (Jain, 1993). Anemia can be diagnosed by reduced packed cell 
volume (PCV) and increased hemolysis (Jain, 1993). Table 2.3 summarizes some normal 
clinical chemistry values for mallards. Reference values were not obtained for several 
endpoints. 
Table 2.3 Reported Clinical Chemistry Values for Mallard Ducks 
Parameter Normal Values 
Packed cell volume (PCV) 33.9 - 48.0 
Heterophils8 2.6 - 13.3 
Eosinophils a 0.25 - 1.44 
Lymphocytesa 1.97 - 10.42 
Monocytesa 0.04 - 0.57 
Basophilsa 0.06 - 0.71 
Albuminb 1.5 - 1.7 
Total proteinb 3.56 - 4.61 
Glucoseb 185 -215 
Aspartate aminotransferase (ASTY 15.8 -16.2 
Calciumb 9.4 - 9.8 
Magnesiumb 1.8 
Phosphorusb 2.9 - 3.0 
Creatinined 0.25 - 0.28 
Uric acidc 4.0 - 4.5c 
Sources: Driver, 1981. and Fairbrother, 1990 
8 Units • 103 /ul 
b Units mg/dl 
CIU/L 
d Units g/dl 
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CHAPTER 3 METHODS 
3.0 Field Survey 
In June 1995, a brief field survey was conducted on the Alamosa River by personnel 
from the U.S. Fish and Wildlife Service (USFWS), U.S. EPA Region VIII, and Colorado 
State University's (CSU) Department of Environmental Health. Mallards were collected 
from the Terrace Reservoir and wetland areas on the Alamosa River, upstream from the 
reservoir and below the Wightman Fork (Figure 2.1). USFWS biologists used tin-
bismuth shot to collect the juvenile birds. An EPA veterinary toxicologist preformed full 
necropsies as soon as the mallards could be retrieved and weighed. The maximum 
amount of time that elapsed between collection and necropsy was approximately 10 
minutes. Liver and kidney samples collected for metals analysis were placed in 15 ml 
polypropylene tubes and stored on ice. Liver and kidney samples collected for 
histopathological analysis were stored in 10% neutral buffered formalin (NBF). Soil, 
water, sediment, and vegetation samples were collected from each location where a bird 
obtained. When it was possible, macroinvertebrate samples were also collected. 
The Alamosa National Wildlife Refuge (NWR) was selected as reference site for this 
study. Several attempts were made to collect similar aged birds from this site. 
Unfortunately, juvenile mallards in the area had already fledged and no birds were 
collected from the Alamosa NWR. Fortunately, metal tissue data collected by Andrew 
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Figure 3.1 Sampling Sites 
Circles identify sampling locations 
Archuleta (USFWS) from the Monte Vista NWR during 1989-1990 were available as a 
source of reference site values (1992). 
Environmental Science and Engineering, Inc. (ESE) performed the metals analyses of 
the duck tissues and the macroinvertebrate samples. Colorado State University' s So~l, 
Water and Plant Testing Laboratory (SWPTL) performed the metals analysis of the 
water, sediment, and vegetation samples. Samples submitted to ESE and CSU SWPTL 
were digested in concentrated nitric acid and analyzed by inductive coupled plasma 
atomic absorption spectrophotometry (ICP-AA) for the concentrations of Al, Cd, Cu, Fe, 
Mo, and Zn using EPA method 7210. 
3.1 Laboratory Studies 
Six laboratory studies were conducted at CSU between the fall of 1995 and the spring 
of 1997 to evaluate the toxicity of copper in juvenile mallards. Because the six studies 
were conducted successively the results from the preceding study were used to influence 
the design of the subsequent studies. 
3.1.1 Animal Care 
Day old mallards were purchased from Whistling Wings, Inc. (Hanover, IL). The 
ducklings were sent by over-night delivery to the Laboratory Animal Resources Center at 
CSU. Upon arrival the two day old ducklings were examined and randomly placed into 
poultry brooder units. Randomization was achieved by removing birds from the 
shipment box and distributing them one at a time into separate incubation units. In this 
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manner the size of each unidentified group was increased at the same rate. Once all of 
the birds were allocated to an incubation unit, each of the brooder units was assigned to 
an experimental treatment by random drawing. 
For the duration of the study, the mallards were kept in brooder units under controllecj. 
temperature and lighting at a CSU Laboratory Animal Resources facility. Mallards were 
raised according to a protocol approved by the CSU Animal Care and Use Committee. 
Assistance with animal care was provided by Laboratory Animal Resource staff (Study 
One), Jennifer Sadler and Suzanne Worker (Studies Two, Three, Four, Five and Six). 
Room temperature was maintained between 22-28 °C and each brooder unit had a 
small heating source that allowed the birds a temperature gradient within the brooder. 
Ambient light was provided by overhead fluorescent lights on an automatic timer set to a 
photoperiod of 16 hours of light and 8 of hours dark. The length of the photoperiod was 
selected to match the natural light during late May and June, when juvenile mallards 
would be present on the Alamosa River. 
The mallards were given free access to feed and water at all times. Water was 
provided in stainless steel troughs and feed was provided in galvanized steel troughs. 
The same lot of commercial game bird starter feed purchased from Ranch - Way Feeds 
(Ft. Collins, CO) was used in all six studies. Without added copper this feed contained 
25 - 27 mg/kg of copper (N = 6), 28% protein (w/w), and 2.5% fat (w/w). Feed samples 
were collected in 50 ml polypropylene tubes and submitted to the CSU Soil, Water and 
Plant Testing Laboratory for analysis. Prior to analysis the samples were baked at 60-70 
°C for 24 hours, ground, weighed (at room temperature), and digested with nitric acid and 
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heat. The feed samples were analyzed by ICP-AA according to EPA methodology 7210. 
The manufacturer reported the percentage of fat and protein in the diet. 
Drinking water samples were collected in 5 ml polyethylene containers and acidified 
with 10% nitric acid. Analysis of drinking water was performed at the CSU DepartmeI].t 
of Environmental Health's Analytical Toxicology Laboratory using flame atomic 
absorption spectrophotometry (FLAA). Details of the FLAA methodologies used in this 
investigation and quality assurance / quality control (QA/QC) are presented in Section 
3.1.6. 
All mallards were given an acclimation period prior to initiation of the experimental 
treatments; the typical acclimation period was 24 hours. However, when then number of 
birds in a study exceeded the number of post-mortem evaluations that could be performed 
in a single day, the acclimation periods for some treatments groups were extended. 
The mallards were housed and treated in groups of 5-9 duckling. Individual birds were 
identified with color coded and numerically labeled plastic leg bands. A specific color 
and number sequence was assigned to each group. Leg bands were placed on the 
individual birds during the first week of treatment. Prior to this time the ducklings were 
too small and the leg bands would fall off. During the course of treatment the leg bands 
had to be changed to accommodate the rapid growth of the mallards. 
Copper treatments were administered in feed for Studies One and Two and in drinking 
water for Studies Three, Four, Five and Six. Treatment protocols are described in Section 
3 .3. During the exposure period, weight gain, feed and water consumption was measured 
at regular intervals. The body weight of each duck was measured at the beginning of the 
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study and twice weekly until the end of the study. The birds were weighed on a digital 
balance that was accurate to the nearest 0.01 g. The balance was designed to weigh live 
animals and corrected for movement by reporting an average reading for a 10 second 
period. 
Feed consumption was measured in all six studies, and water consumption was 
measured in all of the drinking water studies. Feed and water consumption was measured 
by treatment groups rather than individuals. When new quantities of feed or water were 
added, the weight of the new feed/water, and the weight of the residual feed/water were 
recorded. Feed and water weights were obtained with a spring scale accurate to the 
nearest 1 g. In Studies Four, Five, and Six, when additional quantities of water were 
added and the previous portions were removed, drinking water pH was measured with a 
portable pH meter. The pH meter was accurate to the nearest 0.1 pH unit and was 
calibrated daily. 
Daily feed and water consumption was calculated for each treatment group by 
subtracting the residual feed and water weight from the weight of the quantity added on 
the previous day. The consumption data were used to estimate daily dose, which was 
expressed as gram per gram body weight per day (gig BW/d). The feed and water 
consumption data were converted to dose units by dividing the mass of feed or water 
consumed on a given date by the aggregate weight of the group on that day, and this 
quantity was then multiplied by the measured concentration of copper in the medium. 
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3.1.2 Chemicals 
All of the reagents used in this investigation were obtained from a commercial vendor. 
Copper treatments were prepared from reagent grade copper (II) sulfate * 5 H2O 
(powder), copper (II) acetate monohydrate (crystalline), or copper (II) carbonate basic 
(powder) obtained from Fisher Scientific (Springfield, NJ). Analytical chemistry was 
performed with analytical grade nitric acid (Fisher Scientific). 
3.1.3 Experimental Treatments 
3. 1.3.1 Study One 
The specific aim for Study One was to determine a minimum concentration of dietary 
copper that would produce toxicity in juvenile mallards. The study included three 
treatment groups and a control group. Copper, as cupric sulfate, was added to feed in 
concentrations of 200, 400, and 800 mg Cu/kg feed. The highest exposure concentration, 
800 mg/kg, was selected because this concentration of dietary copper had been reported 
to produce adverse effects in turkey poults (Waibel, 1963). The control group was 
provided with untreated feed and all treatment groups were provided with deionized 
water. Each treatment group consisted of 6-8 ducklings. Mallards were given a 24 hour 
acclimation period prior to the initiation of experimental treatments. Copper treatments 
were administered from the third day post-hatch until the thirty-eighth day post-hatch. 
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. The length of the study was determined by body weight. When the mean body weight 
for the control group was equivalent to fledging birds, 750 - 817 g (EPA, 1993), the study 
was terminated. 
The copper enriched diets were prepared by incorporating powdered cupric sulfate into 
a commercial feed with a stainless steel mixer. Copper was a weighed in plastic weigh 
boat on a top-loading digital balance accurate to the nearest 0.0lg. The feed was stored 
in plastic bags and kept in large plastic containers with tight-fitting lids. Samples from 
each feed batch were collected in 15 ml polypropylene tubes for metals analysis. 
3.1.3.2 Study Two 
The specific aim for this study was to compare the toxicity of dietary cupric acetate 
and cupric sulfate. The study was designed to provide the two treatment groups with 
equal concentrations of copper as either cupric sulfate or cupric acetate. Unfortunately, 
an error in the feed preparation resulted in a copper concentration for the copper sulfate 
diet that was approximately half the concentration of the copper acetate diet. The control 
group was given untreated feed and all groups were provided with deionized water. Each 
group contained 8 ducklings. All of the birds were given a 24 hour acclimation period. 
Copper treatments were administered from the third day post-hatch until the thirty-eighth 
day post-hatch. 
Copper was incorporated into the feed by the addition of concentrated solutions of 
either cupric sulfate or cupric acetate. The copper solutions were mixed into the feed 
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using a stainless steel mixer. The treated feed was placed in large polyethylene tubs, 
covered with nylon mesh, and dried at room temperature for 48 hours. After drying, the 
feed was stored in plastic lined containers with tight fitting lids. Feed samples from each 
batch were collected in 15 ml polypropylene tubes for metals analysis. 
3.1.3 .3 Study Three 
The specific aims for Study Three were to determine a concentration of copper in 
drinking water that would produce signs of toxicity and to investigate the influence of pH 
on copper bioavailability. Cupric sulfate was added to deionized water at concentrations 
of 600 and 1200 mg Cu/L. Water pH was adjusted to 3.0 or 4.7 with sulfuric acid and/or 
sodium hydroxide. All treatment groups were provided with untreated feed and the 
control groups were provided with pH adjusted deionized water. The treatment groups 
were given either a 24, 48 or 72 hour acclimation period (Table 3.1). Copper treatments 
were administered on the third, fourth, and fifth day post-hatch and terminated on the 
eighth day post-hatch. This study was designed for 34 day duration, but was terminated 
after 96 hours due to signs of overt toxicity. 
Table 3.1 Treatment Groups in Study Three 
Copper treatment (mg/L Cu) pH N 




















Treatment solutions were prepared with deionized water in 18 L quantities. Copper 
sulfate was weighed in a plastic weight boat on a digital balance and transferred to an 
. 
acid - rinsed polyethylene container. The copper solutions were mixed with a magnetic 
stir bar for at least 20 minutes. Acids and bases were added with Pasteur pipettes to 
achieve the desired pH. 
3.1.3.4 Study Four 
The specific aims for Study Four were to determine a minimum concentration of 
copper in drinking water that would produce signs of toxicity and to investigate the 
influence of pH on copper tissue accumulation. The study included nine treatment groups 
and three control groups (Table 3.2). The acclimation periods for each of the treatment 
groups are summarized in Table 3.3. Copper treatments were administered from the third 
and fourth day post-hatch until the seventeenth and eighteenth day post-hatch. A 14 day 
exposure period was used because the results from the previous investigations indicated 
that treatment effects could be evaluated within this time period. 
Table 3.2 Treatment Groups in Study Four 
pH4.5 N pHS.5 N pH 6.5 N 
Copper in Control 6 Control 5 control 6 
Drinking 2 6 2 6 
Water 10 6 10 6 
(mg/L) 50 7 50 7 50 6 
250 6 250 6 
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Table 3.3 Acclimation Periods in Study Four 
pH4.5 Acclimation pH5.5 Acclimation pH6.5 Acclimation 
period (hr) period (hr) period (hr) 
Copper Control 48 Control 48 control 72 
lil 2 24 2 24 
Drinking 10 24 10 24 
Water 50 24 50 24 50 72 
(mg/L) 250 48 250 48 
Copper was administered to mallards in a soft reconstituted water which was prepared 
with deionized water and the addition of 30 mg/L CaSO4 • H2O, 30 mg/L MgSO4, and 2 
mg/L KCI. Hardness of the reconstituted water was calculated to be between 40-48 mg/L 
of CaCO3 and sulfate levels were calculated to be between 80 - 85 mg/L for all of the 
treatment solutions. The sulfate and hardness levels were selected to approximate the 
conditions found in the Alamosa River in May and June of 1995 and 1996 (Ortiz, 1996). 
Reconstituted water was prepared as a stock solution in large quantities (~ 70 L) in a 
55 gal container. Each treatment solution was then prepared from the stock solution in 
smaller quantity (18 L) by altering the pH and/or the copper concentration of the stock 
solution. Solution pH was adjusted with sulfuric acid and sodium hydroxide. All 
solutions were prepared in acid - rinsed polyethylene containers. Each solution was 
mixed for at least 10 minutes with an electric stir plate and a magnetic stir bar. 
The 250 mg Cu/L treatment was prepared by the addition of cupric sulfate and cupric 
carbonate. This approach was used for two reasons: 1) to maintain the sulfate levels 
within the defined range, and 2) because copper sulfate is insoluble at this concentration. 
After the addition of copper carbonate, the solution was acidified to pH 2.0 by titration of 
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sulfuric acid to liberate some of the carbonate as carbon dioxide. The acidified solution 
was mixed for 10 minutes before the pH was re-adjusted with sodium hydroxide. 
3.1.3.5 Study Five 
The specific aim for Study Five was to evaluate the toxicity of copper and acidic pH 
water between previously observed levels of effect and no effect. Copper was 
administered in reconstituted water at either 117 or 184 mg Cu/L. The copper 
concentrations for this study were selected because they were equally spaced between the 
50 and 250 mg Cu/L. In the preceding study, minimal effects were observed in mallards 
treated with 50 mg Cu/L and substantial health effects were observed in birds treated with 
250 mg Cu/L. Likewise, drinking water pH values of 3.5 and 4.0 were selected because 
no adverse effects were observed in previous study at pH 4.5 and significant effects were 
observed at pH 3.0. 
The soft reconstituted drinking water was prepared as described in Section 3.3.4. The 
117 mg Cu/L treatment was tested at pH 3.5, 4.0 and 4.5. The 184 mg Cu/L treatment 
was only tested at pH 4.5 (Table 3.3). The pH 3.5 and 4.0 control groups were provided 
with soft reconstituted water without added copper. Each group contained 7 birds and the 
exposure period was 14 days. Table 3.5 summarizes the acclimation periods for this 
study. Copper treatments were administered from the third, fourth, and fifth day post-
hatch until the seventeenth, eighteenth, and nineteenth day post-hatch. 
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Table 3.4 Treatment Groups in Study Five 
pH3.5 N 
Copper Control 7 
in drinking water 117 7 
(mg/L) 













3.1.3.6 Study Six 
pH4.0 N pH4.5 
control 7 
117 7 117 8 
184 7 
Acclimation pH4.5 Acclimation 
period (hr) period (hr) 
24 
24 117 48 
184 48 
The specific aim of Study Six was to determine if prolonged exposure to low 
concentrations of copper in drinking water would produced signs of toxicity or 
measurable increases in tissue copper concentrations. In wild populations, the fledging 
period represents the maximum length of exposure for juvenile mallards. The length of 
exposure in this study was 34 days because it was determined in an earlier study that 
mallards raised in the laboratory for 34 days had approximately the same body weight as 
fledging birds. 
Copper was administered in soft reconstituted drinking water at either 2 or 50 mg/L, a 
third treatment group was provided with a "river matrix." The river matrix contained 1.3 
mg Al/L, 2.0 mg Cu/L, 1.8 mg Fe/L, 0.6 mg Mn/L, and 0.3 mg Zn/L. The control group 
was provided with soft reconstituted water without added copper. Drinking water pH for 
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all treatments was 4.5 and each group contained 8 birds. All treatment groups were given 
a 24 hour acclimation period. 
Reconstituted water was prepared as previously described (section 3.1.3.4). The river 
matrix solution was prepared by the addition of: aluminum sulfate, ferric sulfat~, 
magnesium sulfate, zinc sulfate and nickel (II) chloride to reconstituted water. The 
concentrations of all metals, except copper, used in the river matrix were selected by 
reviewing US Geological Survey water quality data for the Alamosa River during the 
months of May and June 1995-6 (Ortiz, 1996). Water pH was adjusted with sulfuric acid 
and sodium hydroxide. 
3.1.4 Necropsy and Tissue Collection 
At the end of each study, the mallards were euthanized by exsanguination under 
anesthesia. Anesthesia was induced with isoflurane, which was delivered from a small 
animal anesthesia machine equipped with a re-breathing circuit and an isoflurane 
vaporizer. The anesthesia mask was modified with a latex glove, which contained a 
narrow slit to create a tight seal around the bird's· head. When a mallard was no longer 
responsive to external stimulus it was removed from the mask and transferred to a sink 
where the jugular vein was punctured with a sharp No. 10 scalpel blade. 
Three blood samples, plasma/serum chemistry, hematology, and residue were collected 
in that order. Hematology samples were collected by draining blood off the tip of a 
scalpel blade into pre-labeled 5 ml tubes containing EDTA. Hematology samples were 
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immediately capped, inverted and then placed in a Styrofoam rack on top of wet ice. 
Plasma chemistry samples were collected by draining blood in pre-labeled 7 ml tubes 
containing heparin. The plasma chemistry samples were immediately capped, inverted 
and spun in a clinical centrifuge for 5 minutes. The plasma was transferred with .a 
Pasteur pipette to a pre-labeled 1.5 µl tube and placed on wet ice. In Study One, serum 
was collected instead of plasma. Serum samples were collected in pre-labeled 7 ml tubes, 
allowed to clot and spun in centrifuge for several minutes. The serum was removed by 
pipette and placed in a pre-labeled 1.5 µl tube. Blood residue samples were collected in 
7 ml tubes and stored at 4 °C. The amount of blood recovered from each bird varied, but 
the minimum volume was approximately 1 ml. On a few occasions there were 
complications in the exsanguination and blood samples could not be collected. 
The spinal column was severed once all of the blood samples were collected. The 
body was then immersed in a weak detergent solution and the breast feathers were 
removed. The bird was transferred to the necropsy table where the peritoneal cavity was 
opened using a mid-line incision. Bile was collected with a 1 cc (ml) syringe and 
transferred to a pre-labeled 1.5 ml tube. The amount of bile recovered from each bird 
varied and on several occasions was not collected, but for birds that were sampled a 
minimum of 0.1 ml was obtained. Bile samples were collected for possible future 
analysis and the data are not included in this thesis. 
The entire liver was dissected and placed in a plastic weight boat. Whole liver weight 
was recorded and two liver samples were collected for histopathological analysis. One 
section was taken from the tip of the left lobe and the other from the point of gall bladder 
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attachment. Both sections were placed in I 0% NBF. The remaining portion of the liver 
was then washed in a 0.9% NaCl solution and divided into two samples: one for residue 
analysis, and one for biochemical analysis. The samples were weighed and placed into 
pre-labeled 7 ml polypropylene tubes. Samples for biochemical analysis were placed in.a 
cooler on dry ice until they could be stored at -80 °C. The residue samples were place in 
a cooler on wet ice until they could be stored at 4 °C. 
Following removal of the liver, the next priority was to collect the kidneys. First the 
spleen and thyroid were removed and then the intestinal tract was deflected to allow 
incisions along both sides of the kidney. The entire kidney was carefully dissected and 
placed in a weight boat. The kidney was weighed and a portion tissue from the area of 
gonadal attachment was removed and placed in formalin. The remainder of the kidney 
was washed in saline and divided into biochemical and residue samples, which were 
weighed and placed in pre-labeled 7 ml polypropylene tubes. The samples for 
biochemical analysis were placed in a cooler on dry ice until they could be stored at -80 
°C. Residue samples were place in a cooler on wet ice until they could be stored at 4 °C. 
The heart was removed and a lateral incision was made to examine the interior of the 
atria and ventricles. Observations of lesions, if present, were recorded. The next tissues 
to be removed were the intestinal tract, proventriculus, ventriculus, crop, and esophagus. 
Scissors were used to open the digestive tract from the esophagus to the cloaca. These 
tissues were examined for lesions and portions from each section were collected. A 
portion of the pancreas, duodenum, and the ileocecal junction were excised and placed in 
formalin. 
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The head was removed from the body, the cranial cavity opened with a small pair of 
rongeurs and the brain carefully removed. The oral cavity was examined for gross 
lesions. The tongue and soft palate were removed with a pair of small scissors. An eye 
was collected with the lachrymal gland attached. 
A piece of skin with feather follicles attached was taken from the region where the 
mid-line incision of the peritoneal cavity was made. A group of primary feathers from 
the wing tip was removed, placed in a zip-lock bag with an identifying label, and stored at 
4 °C for residue analysis. The left tibia tarsus was removed and cracked to collect a 
portion of bone marrow. 
During necropsy a checklist was used to record the bird's identification (leg band 
number and color) and any lesions or abnormal tissue morphology. This check list 
delineated all of the tissues that were harvested and was used to verify that each of these 
were, in fact, taken from the bird. All of the samples were stored in 10% NBF unless 
otherwise noted. Only three tissues were submitted for histopathological analysis: liver, 
kidney and ventriculus. The remaining tissues were collected for possible future analysis. 
Assistance with post-mortem examinations was provided by: Donna Carver, D.V.M. 
Ph.D., Dave Close, D.V.M., Patricia Newell, Cheryl Perkins, Christina Sigurdson, 
D.V.M., Sean Strom, and several students from the CSU Veterinary Medicine class of 
2000. 
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3.1.5 Tissue Copper Analysis 
Flame atomic absorption spectrophotometry (FLAA) was used to measure the copper 
levels in various tissues. These analyses were performed in the CSU Department of 
Environmental Health' s Analytical Toxicology Laboratory. Assistance with metals 
analyses was provided by Patricia Newell, Cheryl Perkins, and Sean Strom. 
Prior to analysis, all of the tissue samples were digested with concentrated nitric acid 
(70%) and microwave heat. All of the glass- and plasticware used for metals analysis 
were pre-rinsed with 10% nitric acid (v/v). 
The liver and kidney samples were weighed on a digital balance and then placed in a 
digestion vessel with 10 volumes (w/v) of nitric acid. Feather samples were weighed, 
washed in 0.1 % Triton-X detergent solution, rinsed three times with deionized water, cut 
into small pieces, and then placed in a digestion vessel with 10 volumes of nitric acid. 
Coagulated whole blood samples were homogenized in 2 ml of deionized water with a 
Teflon pestle; approximately 1 ml of the blood suspension was placed in a digestion 
vessel with 10 volumes (v/v) nitric acid. 
Tissues were left in the digestion vessels for at least two hours before they were placed 
in the rotating carousel of a CEM digestion microwave model MDS 205 (Matthews, NC). 
The process of microwave digestion consisted of heating the samples for a 3 minute 
period at 25% power, allowing the samples to cool to room temperature, reheating the 
samples for 2 minutes at 60% power, cooling, and finally reheating for 2 minutes at 60% 
power. The tissue digests were then transferred to glass volumetric cylinders and the 
digestion vessels were rinsed several times with deionized water. The water from each 
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rinse was added to the volumetric cylinder and the samples were diluted to 20 ml with 
deionized water. Copper concentrations in some samples exceed the upper limit of the 
analytical method and required further dilution. The final volume was recorded and the 
diluted sample was transferred to a 30 ml polypropylene bottle and stored at room 
temperature until analysis by FLAA. 
Sample absorbency was measured at 324.7 nm with a copper-specific lamp in a Varian 
2000 Spectrophotometer (Victoria, Australia). Lamp current was 4 mA and the slit width 
was 0.5 nM. The flame was generated with a mixture of air and acetylene. The air flow 
was 13.5 L/min and acetylene flow was 2.0 L/min. 
Prior to analysis, a calibration curve was generated with a group of copper standards. 
The calibration curve consisted of 0.5, 1.0, 5.0, 10.0 and 50.0 mg Cu/kg copper standards 
prepared in 10% nitric acid. The accuracy of the calibration curve was periodically 
checked with copper standards prepared by the National Bureau of Standards. 
Samples were introduced manually and absorbency was measured with three 
consecutive readings and reported as an average. The measurement time was one second. 
The spectrophotometer was equipped with Varian 2000 software, which correlated mean 
sample absorbency with the calibration curve to provide a measurement of copper 
concentration. The detection limit was dependent on the range of standards used to 
establish the calibration curve; for tissue analysis the detection limit was typically 0.1 mg 
Cu/kg. 
Quality control and quality assurance (QA/QC) techniques were applied for all 
analyses. Each set of samples included at least two duplicate samples, three reagent 
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blanks and four spike samples. Sample spikes were prepared by the addition of a known 
quantity of copper standard to a duplicate sample prior to digestion. The coefficient of 
variation between duplicates ranged from 1.2 - 16.1 %. Percent recoveries for spiked 
samples ranged from 83 .1 - 110 .1 %. 
All of the raw FLAA data were entered into an Excel® spreadsheet (Microsoft, 
Redmond WA). These data were used to calculate tissue copper concentration as 
follows: 
1) The mean absorbency for the blanks was subtracted from the sample reading. 
2) The final volume of the sample was multiplied by the corrected sample absorbency 
and divided by the initial sample weight. 
In Studies Three, Four, and Five, the moisture content of the liver samples was 
measured by placing a known weight of liver in a pre-baked aluminum weight boat. The 
sample was weighed and then dried at 80 °C for 24 hours. The percent moisture was 
calculated by dividing the sample's dry weight by the wet weight, subtracting this 
number from 1, and multiplying by 100. 
3.1.6 Metallothionein Analysis 
Concentrations of hepatic metallothionein were measured in the liver samples collected 
for biochemical analyses. The samples collected for this assay were stored at -80 °C 
until analysis. Tissue samples were analyzed for both the copper bound fraction (Cu -
MT) and the total amount of heat stable copper binding protein (T - MT). 
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All of the tubes and glassware used in the MT assay were pre-rinsed with 10% nitric 
acid. Approximately 1 g of tissue was homogenized in four volumes (w/v) 
homogenization buffer (50 mM Tris-HCI, pH 7.4) using a Teflon pestle. An aliquot of 
homogenized liver was analyzed for protein content. The remainder of the homogenat.e 
was centrifuged at 15,000 x g for 10 minutes. The supernatant was heated at 100 °C for 
10 minutes. After heat treatment the sample was vortexed, cooled on ice, and centrifuged 
at 15,000 x g for 10 minutes. The supernatant fraction was diluted with an equal volume 
of homogenization buffer. Aliquots (200 µl) of the diluted heat-treated supernatant 
fraction were transferred to a 1.5 ml tube for copper saturation/chelex treatment (in 
triplicate for both T -MT and Cu - MT and a single sample for protein analysis). 
Copper saturation/chelex treatment was performed by adding 10 µl of 1 mM copper 
acetate monohydrate to tubes for T - MT determination and 10 µI of 1 mM sodium 
chloride to tubes for Cu - MT determination. Tubes were shaken and then spun on a tube 
rotator for 10 minutes. After mixing, 200 µI of a 66% (v/v) suspension of chelex 100 
ion-exchange resin in Tris-HCI was added to each tube to remove unbound copper and 
the tubes were rotated for 15 minutes. The chelex treated samples were centrifuged and 
the supernatant was acidified with 2.5 ml of 1 % nitric acid (v/v), capped, vortexed and 
stored at room temperature for a minimum of 12 hours before analysis by FLAA. The 
metals analysis homogenate was digested by adding 350 µl of concentrated nitric acid 
(70% v/v) and heating at 100 °C under a fume hood for 10 minutes. Instrument 
conditions and quality assurance protocols for metals analysis are described in Section 
3.1.5. 
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Total protein analysis on the homogenate and supernatant fractions was performed in 
96 well plates using a modification of the Coomassie® Reagent kit colormetric assay. 
Briefly, either sample or standard (10 µl) and 250 µl of Coomassie® Reagent to was 
added to each well, the plate was mixed for 30 seconds on a platform shaker, and the 
absorbency of the protein-dye complex was measured in a plate reader at 600 run. 
Samples were run in triplicate and every fifth sample was a duplicate. A standard curve 
was prepared with dilutions of bovine serum albumin. Results for FLAA were corrected 
for protein content and reported as µg Cu/ g protein. 
3.1. 7 Clinical Chemistry 
Plasma or serum samples were submitted to the CSU Veterinary Teaching Hospital's 
Clinical Pathology Laboratory for an "Exotic Profile 2." Serum was analyzed in Study 
One and plasma samples were used in all of the later studies at the request of Clinical 
Pathology Laboratory. Clinical chemistry analysis was performed with a Hitachi 911 
Auto Sampler (Tokyo, Japan). The assays included in the avian panel were glucose, 
blood urea nitrogen (BUN), uric acid, albumin (A), globulin (G), A/G ratio, creatine 
kinase (CK), aspartate aminotransferase (AST), calcium, phosphorus, sodium, potassium, 
chloride, bicarbonate, anion gap, lipemia, hemolysis, and icterus. A novel procedure for 
analysis of creatine. Creatine is found in the serum and plasma of birds and reptiles and 
may be an indicator of renal function. Metabolism of creatine leads to the production of 
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hydrogen peroxide. Plasma creatine concentrations were determined by a colormetric 
indication of hydrogen peroxide generation (V app, 1997). 
3.1.8 Hematology 
Whole blood samples were submitted to the CSU Veterinary Teaching Hospital's 
Clinical Pathology Laboratory. Hematology samples were analyzed for total white blood 
cell (WBC), heterophil, lymphocyte, monocyte, eosinophil, basophil, plasma protein, and 
packed cell volume (PCV). The Eosinophil Unopette Method was used to indirectly 
calculate the total WBC manually with a hemocytometer. The differential count of the 
percent of heterophil, lymphocyte, monocyte, eosinophil, basophil was determined on a 
smear of blood stained with a Wright's stain. Total solids was determined with a 
refractometer and packed cell volume was measured by centrifugation in a hematocrit 
tube. 
3. 1.9 Histopathology 
The following tissues were collected at necropsy for histopathological evaluation: 
liver, kidney, gonads, adrenal gland, spleen, gall bladder, esophagus, proventriculus, 
ventriculus, small intestine, duodenum, ileocecal junction, pancreas, heart, bursa, skin, 
tongue, soft palette, eye, lachrymal gland, brain, and bone marrow. All tissues were 
preserved in 10% neutral buffered formalin. Only liver, kidney and portions of the 
digestive tract were submitted for evaluation by a pathologist because of the cost 
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associated with histopathological analysis. Slide cassettes were prepared and sent to the 
CSU Histopathology Laboratory to be embedded in paraffin, sectioned, mounted, and 
stained. Hematoxylin and eosin staining was used in all six studies. In Study One 
additional slides were prepared with, rhodonein, a copper specific stain. All slides were 
read by a Board-certified veterinary pathologist without knowledge of the treatment 
status of the specimen. 
3. 1. 10 Statistical Analysis 
All data were evaluated using the Student Edition of Minitab® for Windows® release 9 
or Minitab® 10.0 for Windows® (Addison - Wesley Publishing, Reading MA). 
Analysis of variance (ANOV A) and Tukey' s pair-wise comparisons were used to identify 
significant differences between groups (a.= 0.05, p < 0.05). Regression analysis for was 
used to determine the correlation between two variables. All other analyses were 
performed in Microsoft Excel® for Windows. 
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CHAPTER 4 RESULTS 
4.0 Field Study 
During the last week of June 1995, juvenile mallards and environmental samples were 
collected from the Terrace Reservoir and wetlands along the Alamosa River. The field 
sampling was scheduled to occur when juvenile mallards were expected to be near the 
end of their fledging period. Unfortunately, in the course of a week only six mallards 
were obtained on the Alamosa River and none were collected from the reference site. 
The six birds included one adult female and two juvenile mallards from the Terrace 
Reservoir and three juvenile mallards from wetland areas upstream from the reservoir 
(Figure 2.1 ). 
Metals analysis of the environmental samples indicates that copper concentrations are 
not uniformly distributed throughout the Alamosa River Basin (Table 4.1). Samples 
collected from the Terrace Reservoir contained substantially greater copper 
concentrations than those collected in the wetlands. Sediment samples from the wetlands 
and the Terrace Reservoir contained similar concentrations of copper. The wetland 
sediments with elevated copper concentrations might actually be river sediments that 
were carried into the wetlands during periods of high flow. 
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Table 4.1 Copper Concentrations in Environmental Samples Collected during the 
Field Survey 
Sample Type Wetlands Terrace Reservoir 
Water (N =2) 





a Mean ± standard deviation 
b Units mg Cu/L 
c Composite sample, units µg Cu/g 
0.01 ±Oab 





0.35 ± 0.01 ab 





Liver copper concentrations were lower in mallards collected from wetland areas when 
compared to birds collected in the Terrace Reservoir (Table 4.2). Compared to the 
mallards collected at the Monte Vista NWR, mallards from both the wetlands and the 
Terrace Reservoir had substantially higher liver copper concentrations (Table 4.2). 
Copper concentrations in all kidney samples were below the detection limit (24.6 µgig 
WW). 
Table 4.2 Liver Copper Concentrations of Mallards Collected in the Field Survey 
Sample Origin N Liver Copper Liver Copper Range 
Wetlands Guveniles) 
Alamosa River Guveniles) 
Alamosa River (adult) 
Monte Vista NWR (adultsY 





(µg Cu/g DW) (µg Cu/g (µg Cu/g 
187.9 ± 70.6ab 
478.7 ± 90.4b 
929.1 b 
60.7 ± 51.9 
WW) WW) 
53.0 ± 19.9a 36.3 - 75.1 
135.0 ± 25.5 117.0 - 153.0 
262.0 262.0 
d d 17.1±14.6 1.5- 38.6 
b These numbers are dry weight estimations, calculated with 71.8% moisture. 
c Data from Archuleta, 1992. 
dWet weight values were calculated from the reported mean percent moisture (71.8%). 
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4.1 Study One 
In Study One, mallards were fed either a copper treated diet or a control diet for 34 
days beginning on the fourth day post-hatch. Three copper treatments: high, medium 
and low were tested. Measured concentrations of copper in the feed are reported in Table 
4.3. Copper concentrations in the high copper treatment diet varied by almost 50%, 
indicating that the powered copper sulfate was not evenly distributed in the feed. 
Table 4.3 Dietary Copper Concentrations in Study One 
Control Low Medium 
Calculated NA 200 400 
Analyzed 25 .5 ± l. 5ab 218.5 ± 58.7ab 420 ± 87.7ab 
a Units are mg Cu/kg feed 
b Mean ± standard deviation, N = 3 
4. 1. 1 Weight Gain and Feed Consumption in Study One 
High 
800 
1024.0 ± 503 .5 ab 
Weight gain in the medium and high exposure groups was significantly reduced (p < 
0.05) when compared to the control group (Table 4.4). Weight gain for the high 
treatment group was 15% lower than the control group mean. No significant differences 
in feed consumption were observed between treatment groups (Table 4.5). 
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Table 4.4 Weight Gain in Study One 
Treatment N Starting Weight (g) 
Control 7 59.9 ± 6.1 
Low 6 62.8 ± 5.3 
Medium 7 58.1 ± 4.4 
High 8 59.4 ± 6.1 
a Mean ± standard deviation 
Weight Gain (g) 
775.4 ± 57.1 a 
737.2 ± 70.6 
707.6 ± 64.5 b 
658.7 ± 78.7 C 
Range (g) 
683.9 - 862.4 
641.9 - 857.4 
633.0- 845.9 
551.2 - 758.5 
b Significantly different from control (ANOV A, Tukey's test, p < 0.05) 
c Significantly different from control (ANOVA, Tukey's test, p < 0.01) 








0.22 ± 0.09a 
0.26 ± 0.11 
0.27± 0.13 
0.24± 0.12 
a Mean ± standard deviation from 6 observations 
4.1.2 Tissue Copper Concentrations in Study One 
There were no significant differences in liver copper concentrations between treatment 
groups (Table 4.6). However, feather copper concentrations increased significantly with 
copper exposure (Table 4.7). A 2- and 3-fold increase in feather copper concentrations 
was observed in the medium and high treatment groups (Table 4.7). 
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Table 4.6 Liver Copper Concentrations in Study One 
Treatment N Liver Copper 
(µg Cu/g WW) 
Control 7 155.7 ± 16.6 a 





a Mean ± standard deviation 
143.8 ± 35.1 
183.6 ± 17.0 
Table 4.7 Feather Copper Concentrations in Study One 
Treatment N Feather Copper (µg Cu/g) 
Control 7 22.7 ± 5.7a 
Low 6 35.3 ± 22.1 
Medium 7 48 .7 ± 8.3b 
High 8 66.8 ± 6.7bc 
a Mean ± standard deviation 
Range 
(µg Cu/gWW) 
100.8 - 196.3 
92.2 - 205.5 
63.1 - 234.3 
121.1 - 266.9 
Range (µg Cu/g) 
15.6 - 32.2 
9.6 - 64.4 
41.2 - 62.0 
56.0 - 73.2 
b Significantly different from the control (ANOVA and Tukey' s test, p < 0.001) 
c Significantly different from all other groups (ANOVA and Tukey's test, p < 0.001) 
4. 1.3 Clinical Chemistry and Hematology Results for Study One 
No significant differences were seen in any of the measured serum chemistry or 
hematology values (Tables 4.8 and 4.9). There was a wide range in the reported AST 
values, and the mean AST values for all of the treatment groups were larger than the 
reported range, 15.8-16.2 IU/L (Table 2.3). The glucose results for the medium treatment 
group were below the reported normal range, 185-215 mg/dl (Table 2.3). 
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Table 4.8 Serum Chemistry Result for Study One 
Treatment Control a Low a Medium a 
Glucose 
Uric acid b 










(N = 7) 
186.0 ± 1.5 
12.6 ± 3.4 
3.6 ± 0.3 
1.4 ± 0.6 
2.2 ± 0.6 
0.7 ± 0.3 
109.0 ± 85.5 
10.6± 0.4 
8.6 ± 0.9 
19.0± 10.2 
29.9 ± 23.1 
0.9 ± 0.4 
(N=6) 
190.0 ± 9.0 
8.2 ± 4.1 
3.8 ± 0.4 
1.7 ± 0.2 
2.0 ± 0.2 
0.9 ± 0.1 
38.5 ±12.1 
11.1 ± 0.4 
7.1 ± 0.8 
13.3 ± 7.5 
13.5 ± 6.5 
0.8 ± 0.4 
a Reported as mean ± standard deviation 
b Units are mg/dl 
c Units are g/dl 
d Units are IU/L 
Table 4.9 Hematology Results for Study One 
Treatment Control a 200 a 
(N = 7) (N = 6) 
WBC6 8.9 ±4.7 18.3±7.9 
Heterophils b 4.9 ± 3.2 8.5 ± 3.1 
Lymphophilsb 3.2 ± 1.5 8.5 ± 5.9 
Monocytes b 0.2 ± 0.2 0.6 ± 0.7 
Eosinophils b 0.2 ± 0.1 0.5 ± 0.2 
Basophils b 0.5 ± 0.3 0.8 ± 0.6 
Plasma proteinc 4.1 ± 0.5 4.2 ± 0.4 
PCV(¾) 38.8 ± 3.2 38.0 ± 1.9 
a Reported in mg Cu/kg as mean ± standard deviation 
b Units are * 103 /µl 
c Units are g/dl 
4.1.4 Histopathology Results for Study One 
(N = 7) 
167.7 ± 6.8 
3.6 ± 0.6 
3.7 ± 0.2 
1.7 ± 0.1 
2.0 ± 0.1 
0.8 ± 0.1 
42.0 ± 10.3 
11.0 ± 0.2 
7.2 ± 0.3 
7.9 ± 4.8 
12.0 ± 6.6 
1.0 ± 0.0 
400 a 
(N = 7) 
9.5 ± 3.7 
5.2 ± 2.8 
3.4 ± 1.7 
0.8 ± 0.9 
0.2 ± 0.1 
0.5 ± 0.5 
4.0 ± 0.3 
35.3 ± 0.4 
High a 
(N= 8) 
196.1 ± 23.0 
8.9 ± 4.5 
3.8 ± 0.3 
1.7 ± 0.2 
2.0 ± 0.2 
0.8 ± 0.1 
82.6 ± 97.1 
11.5 ± 1.5 
7.8 ± 1.2 
17.9± 21.1 
13.4 ± 10.0 
0.8 ± 0.5 
800 a 
(N = 8) 
14.3 ± 6.1 
7.3 ± 3.1 
6.2 ± 3.8 
0.3 ± 0.2 
0.3 ± 0.3 
0.4 ± 0.3 
4.3 ± 0.4 
36.6 ± 3.4 
Moderate to severe pathological changes were observed in six of the eight liver 
samples from the control group (Table 4.10). Similar frequencies of liver lesions were 
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observed in the low and high copper treatment groups. Liver lesions included 
hepatocellular swelling and microcavitary degeneration. No difference between 
treatment and control groups was observed in slides that were stained with the copper -
specific stain rhodonien. Kidney lesions included swelling and degeneration of the 
tubular epithelial cells. Nearly all of the ventriculus samples exhibited some degree of 
degeneration in the kaolin layer. It was the pathologist's opinion that the lesions of the 
ventriculus could be artifacts of stress (Spraker, 1996). 
Table 4.10 Frequency of Tissue Lesions in Study One 
Treatment Liver Kidney 
Control 6/8 3/8 
~w ~ l ffi 
Medium 1/7 2/7 






Note: only lesions that were classified as moderate to severe were included in this 
companson 
4.2 Study Two 
In Study Two, mallards were provided with treated feed that contained either copper 
sulfate or copper acetate for 34 days beginning on the fourth day post-hatch. Measured 
concentrations of copper in the feed are reported in Table 4.11. The concentration of 
copper in the acetate diet was approximately twice that of the sulfate diet due to an error 
in feed preparation. 
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Table 4.1 1 Dietary Copper Concentrations (mg/kg feed) in Study Two 
Control Acetate Sulfate 
Calculated 
Analyzed 
(N = 2) 
26.9 ± 1.2a 
a Mean ± standard deviation 
1119 637 
1024.8 ± 121.0a 503.4 ± 57.7a 
4.2.1 Weight Gain and Consumption Rates for Study Two 
At the end of the 34 day exposure period weight gain in the copper sulfate treatment 
group was significantly reduced (p < 0.05) when compared to the control group (Table 
4.12). There were no significant differences in feed or water consumption between 
control and treatment groups (Table 4.13). 
Table 4.12 Weight Gain in Study Two 
Treatment N Starting Weight (g) 
Control 8 56.2 ± 5.2 
Acetate 8 46.8 ± 6.3 
Sulfate 8 54.9 ± 5.5 
a Mean ± standard deviation 
Weight Gain (g) 
897.7± 116.6a 
911.6 ± 100.2 
812.6 ± 87.0b 
Range (g) 
704.9- 1039.9 
773.6 - 1022.6 
676.8 - 977.1 
b Significantly different from control (ANOV A, Tukey's test, p < 0.05) 
Table 4.13 Consumption Rates in Study Two 
Treatment Feed (g/g BW/d) 
Control 0.15 ± 0.04a 
Acetate 0.14 ± 0.04 
Sulfate 0.15 ± 0.04 
a Mean± standard deviation of 34 observations 
49 
Water (ml/g BW/d) 
0.95 ± 0.3 la 
0.99 ± 0.34 
0.99 ± 0.35 
4.2.2 Liver Copper Concentrations in Study Two 
Hepatic copper concentrations in both of the treatment groups were significantly 
increased (p < 0.01) when compared to the control group (Table 4.14). There was a 2-
fold increase in liver copper concentrations for the acetate treatment group when 
compared to the sulfate treatment group. 
Table 4.14 Liver Copper Concentrations in Study Two 







(µg Cu/g WW) (µg Cu/g WW) 
95.1 ± 43.9a 38.0 - 152.3 
352.5 ± 130.6 be 108.8 - 515.5 
153.4 ± 61.i 88.1 - 271.8 
a Mean ± standard deviation 
b Significantly different from control (ANOVA, Tukey's test, p < 0.01) 
c Significantly different from sulfate treatment, (ANOVA, Tukey's test, p < 0.001) 
4.2.3 Clinical Chemistry and Hematology Results for Study Two 
The plasma chemistry results did not demonstrate any significant differences between 
treatment groups (Tables 4.15). Likewise, there were no significant differences in the 
hematology results ( 4.16). The AST result for all treatment groups were greater than 
reported normal range (Table 2.3). 
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Table 4.15 Plasma Chemistry Results for Study Two 
Treatment Control (N = 8) 
Glucose 229.1 ± 29.8 
BUNb 1.6 ± 0.5 
u. "db nc ac1 6.1 ± 2.3 
Creatine b 1.5 ± 0.4 
Total protein C 3.6 ± 0.1 
Albumin C 1.6 ± 0.1 
Globulin C 2.0 ± 0.1 
A/G ratio 0.8 ± 0.04 
ASTd 32.4 ± 18.6 
Creatine kinase d 2122.0 ± 1326.0 
Calcium b 10.6 ± 0.4 
Phosphorus b 7.9 ± 2.5 
Sodium C 145.9 ± 3.9 
Potassium e 7.5 ± 0.9 
Chloride e 110.0 ± 3.4 
Bicarbonate e 23.1 ± 2.5 
Anion gap 15.4 ± 3.2 
Lipemia b 7.1 ± 6.0 
Hemolysis b 8.1 ± 5.9 
Icterus b 0.9 ± 0.4 
a Mean ± standard deviation 
b Units are mg/dl 
c Units are g/dl 
d Units are IU/L 
e Units are meq/L 
Acetate (N = 8) 
223.6 ± 25.7 
1.0± 0.0 
3.6 ± 0.9 
1.7 ± 0.5 
3.7 ± 0.5 
1.6 ± 0.2 
2.1 ± 0.3 
0.8 ± 0.07 
30.3 ± 23.8 
1875.0 ± 1231.0 
10.9 ± 0.6 
7.5 ± 0.9 
144.9 ± 1.1 
7.5 ± 0.9 
110.0 ± 1.5 
22.4 ± 2.2 
15.6 ± 2.6 
6.0 ± 2.9 
12.3 ± 7.5 
0.6 ± 0.5 
Table 4.16 Hematology Results for Study Two 
Treatment Control (N =8) Acetate (N =8) 
WBC a 16.1 ± 10.5 16.8 ± 3.0 





Plasma protein b 
PCV (%) 
a Units * 1 0-' /~tl 













10.0 ± 1.5 
0.4 ± 0.1 
0.2 ± 0.1 
0.4 ± 0.4 
4.2 ± 0.6 
37.8 ± 2.9 
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Sulfate (N = 8) 
200.9 ± 27.3 
1.8 ± 0.5 
4.8 ± 2.3 
1.6 ± 0.5 
3.7 ± 0.2 
1.6 ± 0.1 
2.1 ± 0.1 
0.8 ± 0.05 
34.1 ± 19.4 
2317.0 ± 1580.0 
9.4 ± 4.3 
7.9 ± 2.5 
145.5 ± 2.0 
7.9 ± 2.5 
110.0± 3.7 
22.8 ± 4.5 
18.6 ± 10.5 
13.4 ± 6.3 
9.4± 11.2 
0.3 ± 0.5 
Sulfate (N =8) 
24.3 ± 6.7 
11.0± 3.4 
12.1 ± 6.7 
0.5 ± 0.3 
0.7 ± 0.3 
0.6 ± 0.2 
4.0 ± 0.3 
37.9 ± 3.9 
4.3 Study Three 
In Study Three, mallard ducklings were exposed to copper in deionized water on the 
third to fifth days post-hatch. Exposure concentrations are reported in Table 4.17. This 
study was designed for a 34 day exposure period but was terminated after 4 days due to 
high mortality in both treatment and control groups. The pH 4. 7 control group was 
maintained for 34 days to monitor survival. Clinical chemistry and histopathology 
samples were not collected because the study was terminated prematurely and several of 
the birds were found dead rather than euthanized. 
Table 4.17 Water Copper Concentrations (mg Cu/L) in Study Three 
Treatment pH N Measured concentration 
Control 3.0 4 BDLa 










a Below detection limit (0.1 mg Cu/L) 
b Mean ± standard deviation 
4.3. 1 Mortality in Study Three 
BDL 
607.0 ± 8.2 
1195.2 ± 24.3 
The copper treatments used in this study produced unexpectedly high mortality rates 
(Table 4.18). Exposure to 600 mg Cu/L at pH 4.7 for 96 hours resulted in 63% 
mortality. After 24 hours there was 86% mortality in the 1200 mg Cu/L treatment group. 
An unexpected observation for this study was the decreased survival rate in birds that 
consumed drinking water at pH 3.0 without added copper. Ducklings exposed to 
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drinking water at pH 3.0 without added copper experienced 86% mortality between day 4 
and 5, while the entire pH 4.7 control group survived until euthanasia at day 34. The 
combination of pH 3.0 and 600 mg Cu/L appeared to increase the extent of mortality, and 
reduced the time until first mortality. 
Table 4.18 Morta lity in Study Three 
Treatment pH Mortalities/ Mortality Days of Length of 
(mg Cu/L) Treated (%) Exposure to 1st exposure period a 
Birds Mortality (days) 
Control 3.0 6/9 67 4 5 
600 7/8 88 I 4 
Control 4.7 0/9 0 NA 34 
600 5/8 63 2 4 
1200 6/7 86 1 1 
a When mortality in a treatment group exceed 50% the remaining birds were euthanized. 
4.3.2 Liver Copper Concentrations in Study Three 
The mean liver copper concentrations for ducks that were exposed to 600 mg Cu/L at 
both pH 3.0 and 4.7 were significantly elevated (p < 0.001) when compared to the 
respective control group (Table 4.19). Mean liver copper concentration for the 1200 mg 
Cu/L treatment group was not significantly different (p > 0.05) when compared to the 
respective control group. However, this group was terminated after 24 hours due to the 
high mortality rate, it is possible that the short exposure period precluded the 
accumulation of copper. Exposure to 600 mg Cu/L at pH 4.7 for 96 hours produced a 
mean liver copper concentration that was approximately twice that of ducks, which had 
been exposed to 1024 mg Cu/kg in feed (as copper acetate) for 34 days (Table 4.14). The 
53 
liver copper concentration for the 600 mg Cu/L pH 4.7, but not the 600 mg Cu/L pH 3.0, 
treatment group was significantly greater than the 1200 mg Cu/L pH 4.7 treatment group. 
Table 4.19 Liver Copper Concentrations in Study Three 
Treatment N pH Liver copper Range 
(mg Cu/L) (µg/gWW) (µg/gWW) 
Control 9 3.0 25.6 ± 7.7 a 15.8 - 37.3 
600 8 3.0 290.8 ± 183.2 b 66.0 - 501 .3 
Control 9 4.7 75.6 ± 29.2 cd 51.5 - 138.5 
600 8 4.7 364. 1 ± 132.5 be 142.5 - 500.3 
1200 7 4.7 134.7 ± 135.4 45.5 - 396.4 
a Mean ± standard deviation 
b Significantly different from the respective control (ANOVA, Tukey's test, p < 0.001) 
c 34 day-old bird 
d Significantly different from the pH 3.0 control (ANOVA, Tukey's test, p < 0.01) 
e Significantly different from 1200 mg Cu/L treatment group (ANOVA, Tukey's test, p < 
0.01) 
4.4 Study Four 
In Study Four, mallards were exposed to copper in soft reconstituted water for 14 days 
starting on the third and fourth days post-hatch. Measured water pH and copper 
concentrations are summarized in Table 4.20. 
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Table 4.20 Water pH and Copper Concentrations in Study Four 
Nominal pH pH range Measured N 
(mg Cu/L) (mg Cu/L) 
Control 4.5 4.2 - 4.7 BDLa 4 
2 4.5 4.3 - 4.6 2.3 ± 0.5 b 4 
IO 4.5 4.2 - 4.8 9.7 ± 0.9 4 
50 4.5 4.4 - 4.8 51.6 ± 3.7 4 
250 4.5 4.4 - 5.0 252.4 ± 8.5 4 
Control 5.5 5.4 - 5.7 BDL 4 
2 5.5 5.2 - 5.5 1.9 ± 0.7 4 
IO 5.5 5.2 - 5.6 10.l ± 1.0 4 
50 5.5 5.4 - 5.7 48.7 ± 4.1 4 
250 5.5 5.5 - 5.9 249.3 ± 10.2 4 
Control 6.5 6.4 -6.7 BDL 4 
50 6.5 6.5 -6.6 52.4 ± 4.5 4 
a Below detection limit (0.1 mg Cu/L) 
b Mean ± standard deviation 
c Units mg Cu/L 
4.4. 1 Weight Gain and Consumption Rates in Study Four 
Weight gain was significantly reduced (p < 0.001) in mallard ducklings that were 
exposed to 250 mg Cu/L copper at both pH 4.5 and 5.5 when compared to their respective 
control groups and all other treatment groups (Table 4.21 ). Mean weight gain for both 
250 mg Cu/L treatment groups were less than 50% of the respective control group means. 
During the last week of treatment, the ducklings in 250 mg Cu/L treatment groups were 
noticeably weak and listless. 
Weight gain for all three of the 50 mg Cu/L treatment groups was reduced by more 
than 15% when compared to the respective control groups. Reduced weight gain (20%) 
was also observed in the 2 mg Cu/L pH 5.5 treatment group. There were no significant 
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differences (p > 0.05) in weight gain between the different pH groups, which received the 
same copper treatment. 
Table 4.21 Weight Gain in Study Four 
Treatment (mg Cu/L) pH N Starting Weight (g) Weight Gain (g) 
Control 4.5 6 55.5 ± 8.4 256.5 ± 40.2a 
2 4.5 6 60.7 ± 5.3 231.9 ± 27.5 
10 4.5 6 60.1 ± 6.9 242.5 ± 29.6 
50 4.5 7 58.4 ± 7.2 184.2 ± 26.4b 
250 4.5 6 57.4 ± 6.6 94. 7 ± 46.2bc 
Control 5.5 5 61.7 ± 3.9 224.6 ± 16.7 
2 5.5 6 49.2 ± 6.5 180.2 ± 28.8b 
IO 5.5 6 66.9 ± 7.5 258.9 ± 46.1 
50 5.5 7 54.5 ± 5.9 183.4 ± 25.8b 
250 5.5 6 60.3 ± 4.3 73.8 ± 39.8bc 
Control 6.5 6 59.4 ± 6.3 237.3 ± 11.7 
50 6.5 6 61.2 ± 5.6 198.2 ± 26.3 
a Mean ± standard deviation 
b Significantly different from the respective control (ANOVA and Tukey's test, p < 
0.001) 
c Significantly different from all other treatment groups with the same pH (ANOV A and 
Tukey's test, p < 0.001) 
There were no significant differences among mean feed consumption rates for any of 
the treatment groups (Table 4.22). Likewise, there were no significant differences in 
water consumption between treatment groups. 
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Table 4.22 Feed and Water Consumption Rates for Study Four 
Treatment pH Feed Water 
(mg Cu/L) (gig BW/d) (gig BW/d) 
Control 4.5 0.23 ± 0.07a 1.12 ± 0.22a 
2 4.5 0.18 ± 0.07 1.06 ± 0.22 
10 4.5 0.23 ± 0.07 1.16 ± 0.09 
50 4.5 0.24 ± 0.06 1.14 ± 0.23 
250 4.5 0.22 ± 0.11 1.67 ± 0.27 
Control 5.5 0.24 ± 0.08 1.00 ± 0.10 
2 5.5 0.28 ± 0.08 1.37 ± 0.36 
10 5.5 0.24 ± 0.06 1.21 ±0.06 
50 5.5 0.25 ± 0.09 1.03 ± 0.25 
250 5.5 0.18 ± 0.09 1.76 ± 0.41 b 
Control 6.5 0.22 ± 0.07 1.15±0.13 
50 6.5 0.24 ± 0.06 1.42 ± 0.41 
a Mean ± standard deviation for 12 observations 
b Significantly different from the control (ANOVA, Tukey's test, p < 0.001) 
4.4.2 Tissue Copper Concentrations in Study Four 
Mallards in the 250 mg Cu/L treatment groups at both pH 4.5 and 5.5 had elevated 
liver copper concentrations (Table 4.23). One individual in the 250 mg Cu/L treatment 
group (pH 5.5) had an exceptionally high concentration of copper, 5749 µg Cu/g DW. 
When the mean hepatic copper concentrations were calculated, the individual with the 
largest hepatic copper concentration was excluded because it appears to be an outlier (i.e., 
more than 4 standard deviations above the mean) (Kleinbaum, 1988). Mean liver copper 
concentrations for the 250 mg Cu/L treatment groups at both pH 4.5 and 5.5 were 
significantly increased (p < 0.001) when compared to the respective control groups. 
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Table 4.23 Liver Copper Concentrations in Study Four 
Treatment pH N Liver Copper Range 
(mgCu/L) (µg Cu/gDW) (µg Cu/gDW) 
Control 4.5 6 199.8 ± 75.9a 85.2 - 286.5 
2 4.5 6 295.5 ± 93.3 201.6 - 460.5 
IO 4.5 6 185.6 ± 82.9 89.3- 318.5 
50 4.5 7 197.3 ± 82.3 110.9 - 339.5 
250 4.5 6 1546.7 ± 408.6 b 1100.8 - 2129.1 
Control 5.5 5 335.l ± 134.7 231.5 - 555.1 
2 5.5 6 216.1 ± 90.l 141.1 - 367.9 
10 5.5 6 252.9 ± 56.4 202.0 - 347.0 
50 5.5 7 174.4 ± 56.6 73.6 - 234.5 
250 5.5 6 1524.1 ± 746.5 be 857.4 - 2510.1 
Control 6.5 6 228.3 ± 62.7 120.6 - 275.3 
50 6.5 6 137.6 ± 36.7 64.6 - 164.5 
a Mean ± standard deviation 
b Significantly different from the respective control group (ANOVA, Tukey's test, 
p < 0.001). 
c An outlier, with 5748.9 µg Cu/g, was excluded from the mean. The mean± standard 
deviation including the outlier is 2228.3 ± 1849.5. 
There were no significant differences (p > 0.05) between the blood copper 
concentrations in the 250 mg Cu/L treatment groups and their respective control groups 
(Table 4.24). Kidney copper concentrations for both the 250 mg Cu/L treatment groups 
were significantly greater (p < 0.05) than the respective control group means (Table 
4.25). The mallard with the exceptionally large hepatic copper concentration also had 
very high concentration of copper in its kidney. The kidney copper concentration for this 
individual was more than 4 standard deviations greater than the group mean so it was 
treated as an outlier and also omitted from the calculation of the mean. 
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Table 4.24 Blood Copper Concentrations in Study Four 
Treatment pH N Blood Copper 
(mg Cu/L) (µg Cu/g) 
Control 4.5 4 1.4 ± 0.8a 





a Mean ± standard deviation 
5 
6 
1.4 ± 0.8 
1.8 ± 0.6 
Table 4.25 Kidney Copper Concentrations in Study Four 
Treatment pH N Kidney Copper 
(mg Cu/L) (µg Cu/g) 
Control 4.5 6 4.1 ± 0.6a 
2 4.5 6 4.2 ± 0.6 
10 4.5 6 3.3 ± 0.6 
50 4.5 7 3.9 ± 0.6 
250 4.5 6 9.9 ± 5.6b 
Control 5.5 5 3.6± 0.7 
2 5.5 6 3.3 ± 0.5 
10 5.5 6 5.3 ± 1.6 
50 5.5 7 4.6 ± 2.2 
250 5.5 6 13.4 ± 4.6cd 
Control 6.5 6 3.3 ± 0.4 
50 6.5 6 3.9 ± 0.7 
a Mean ± standard deviation 
Range 
(µg Cu/g) 
0.9 - 2.5 
1.0-3.4 
0.8 - 2.7 
1. I - 2.8 
Range 
(µg Cu/g) 
3.0 - 4.7 
3.4 - 4.9 
2.7 - 4.1 
3.3 - 4.8 
5.9- 21.1 
2.7 - 4.7 
2.7 - 3.8 
3.7 - 7.5 
3.3 - 9.2 
7.7 -18.9 
2.9 - 4.0 
3.0 - 5.1 
b Significantly different from pH 4.5 control (ANOVA, Tukey's test, p < 0.001) 
c The individual with the largest kidney copper concentration, 61.4 µg Cu/g was omitted 
from the mean. The mean± standard deviation including the outlier was 21.4 ± 20.0. 
d Significantly different from pH 5.5 control (ANOVA, Tukey's test, p < 0.05) 
Feather copper concentrations in both the 250 mg Cu/L treatment groups were 
significantly greater (p < 0.001) than their respective control groups (Table 4.26). The 
mean feather copper concentration for the 250 mg Cu/L pH 5.5 treatment groups was 
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significantly greater (p < 0.001) than the mean for the 250 mg Cu/L pH 4.5 treatment 
group. The individual in the 250 mg Cu/L pH 5.5 treatment group with the exceptionally 
large liver and kidney copper concentrations also had the largest feather copper 
concentration, 231 µg Cu/g. However, the feather copper concentration in this individual 
was less than 2 standard deviation greater than the mean, so it was not treated as an 
outlier. The mean feather copper concentration for the 50 mg Cu/L pH 6.5 treatment 
group was significantly greater (p < 0.001) than the pH 6.5 control and all other 50 mg 
Cu/L treatment groups. 
Table 4.26 Feather Copper Concentrations for Study Four 
Treatment pH N Feather Copper Range (µg Cu/g) 
(mg Cu/L) (µg Cu/g) 
Control 4.5 6 15.0 ± 6.8a 6.7 - 22.1 
2 4.5 6 8.8 ± 1.7 7.3 - 10.4 
10 4.5 6 18.4 ± 4.9 14.3 - 25.1 
50 4.5 7 21.5 ± 5.1 15.2 - 26.4 
250 4.5 6 65.0 ± 20.5b 37.6- 93.l 
Control 5.5 5 12.5 ± 3.7 7.2 - 16.1 
2 5.5 6 13.5 ± 3.0 10.8 - 18.3 
10 5.5 6 20.7 ± 10.3 11.2 - 27.1 
50 5.5 7 26.5 ± 7.2 17.2 - 38. l 
250 5.5 6 144.0 ± 64.6 cd 49.7 - 231.0 
Control 6.5 6 13.l ± 2.1 9.6- 13.7 
50 6.5 6 66.3 ± 27.1 ef 43.l - 102.0 
a Mean ± standard deviation 
b Significantly different from pH 4.5 control (ANOVA, Tukey's test, p < 0.001) 
c Significantly different from pH 5.5 control (ANOVA, Tukey's test, p < 0.001) 
d Significantly different from 250 mg Cu/L pH 4.5 (ANOVA, Tukey's test p < 0.001) 
e Significantly different from control, pH 6.5 (ANOVA, Tukey's test, p < 0.001) 
r Significantly different from 50 mg Cu/L pH 4.5 and 5.5 (ANOVA, Tukey's test, p < 
0.001) 
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4.4.3 Clinical Chemistry and Hematology Results for Study Four 
Mean plasma concentrations of total protein, albumin, globulin, uric acid, and 
potassium in the 250 mg Cu/L pH 5.5 treatment group were significantly different (p .< 
0.001) from the respective control group (Table 4.28a). The elevated mean uric acid 
concentration in the 250 mg Cu/L treatment group (pH 5.5) was produced by one bird, 
the individual with exceptionally high liver and kidney copper concentrations. The 
plasma concentration of uric acid in the high copper bird was 17.2 mg/dl. When this 
individual was omitted from the average, the mean ( 4.3 ± 2.3 mg/dl) was not significantly 
increased (p > 0.05). The elevated mean potassium concentration was also associated 
with one bird. The bird with an elevated plasma potassium concentration (14.3 meq/L) 
had increased, but not exceptionally large concentrations of copper in its liver and kidney. 
The mean lipemia values for the 50 mg Cu/L treatment groups at both pH 4.5 and 5.5 
were significantly elevated (p < 0.001) when compared to the respective control groups, 
but the increased means in both cases was created by one individual. The presence of 
elevated plasma lipids can occur if the sample is i_mproperly prepared (Vapp, 1997). No 
significant differences were seen among any of the hematology parameters (Tables 4.27b, 
4.28b, and 4.29b ). 
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Table 4.27a Clinical Chemistry Results from Study Four - I 
Treatment Control, pH 4.5 2, pH 4.5 10, pH 4.5 50, pH 4.5 
Glucose• 210 ± 13 230 ± 21 222 ± 14 216 ± 14 
BUN • 1.3 ± 0.5 1.5 ± 0.6 1.7 ± 0.8 2.1 ± 0.4 
Uric Acid• 3.8 ± 0.6 5.1 ± 1.5 5.1 ± 1.5 4.2 ± 1.1 
Total Protein b 3.2 ± 0.2 3.3 ± 0.3 8.2 ± 11.7 3.2 ± 0.3 
Albumin b 1.6 ± 0.1 1.6 ± 0.2 1.7 ± 0.1 1.6 ± 0.3 
Globulin b 1.6 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 1.6 ± 0.3 
A/G 1.0 ± 0.1 1.0 ± 0.2 1.0 ± 0.1 1.0 ± 0.3 
AST c 46 ± 25 139 ± 144 144 ± 196 123 ± 87 






1.0 ± 0.2 
9.9 ± 0.3 
8.2 ± 0.1 
143 ± 1.4 
3.8 ± 0.2 
114± 1.4 
19.1 ± 1.7 
13.8±2.5 
1.7 ± 1.0 
9.7 ± 0.5 
8.1±0.7 
144 ± 2.5 
4.4 ± 0.7 
114 ±2.8 
17.1 ±1. 1 
17.7±2.1 
10.3 ± 6.4 
2.5 ± 2.5 
10.1 ± 0.6 
8.3 ± 1.2 
146± 1.3 
4.0±0.5 
115 ± 2.6 
17.5 ± 1.5 
18.0 ± 2.1 
8.5 ± 9.8 
1.9 ± 0.9 
10.0 ± 0.4 
8.7 ± 1.5 
147 ± 5.1 
4.3 ± 0.9 
116 ± 4.9 
17.6 ± 1.8 
17.4±2.3 









0.3 ± 0.5 
53.6 ± 44.3 35.8 ± 50.7 35.4 ± 40.9 
0.8 ± 0.4 0.7 ± 0.5 0.6 ± 0.5 
Reported as mean ± standard deviation 
Bold number are significantly different from control (ANOV A, p<0.00 I, a. = 0.05) 
a Units are mg/di 
b Units are g/dl 
c Units are IU/L (* CK units are * 1000) 
d Units are meq/L 
Table 4.27b Hematology Results for Study Four - I 
Treatment Control, pH 4.5 2, pH 4.5 10, pH 4.5 
WBC • 18.0 ± 10.0 6.8 ± 2.9 6.7 ± 3.3 







11.8 ± 10.3 
0.4 ± 0.2 
0.3 ± 0.2 
0.3 ± 0.1 
4.0 ± 0.3 
36.8 ±1.0 
Reported as mean ± standard deviation 
a units* 103/µI 
bUnits g/dl 
2.6 ± 1.4 3.3 ± 2.9 
0.3 ± 0.3 0.6 ± 0.4 
0.1±0.0 0.3 ± 0.0 
0.2 ± 0.1 0.3 ± 0.1 
4.3 ± 0.5 4.2 ± 0.1 
38.0 ± 2.8 37.5 ± 3.6 
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50, pH 4.5 
6.9 ± 1.4 
2.9 ± 0.6 
3.2 ±2.0 
0.4 ± 0.2 
0.3 ± 0.3 
0.3 ± 0.1 
4.1 ± 0.5 
36.2 ± 1.5 
250, pH 4.5 
223 ± 10 
1.5 ± 0.6 
3.0 ± 1.3 
3.0 ± 0.6 
1.5 ± 0.2 
1.5 ± 0.2 
1.1 ± 0.5 
116 ± 167 
5.6 ± 7.2 
1.5 ± 0.4 
9.4 ± 2.2 
7.8 ± 0.9 
145 ± 3.6 
4.6 ±2.5 
114 ± 2.6 
17.0 ± 1.3 
18.6 ± 1.8 
8.2 ± 5.3 
67.3± 110.7 
0.2 ± 0.4 
250, pH 4.5 
11.2 ± 4.4 
5.7 ± 3.2 
5.3 ± 1.7 
0.6 ± 0.3 
0.3 ± 0.0 
0.3±0.1 
3.9 ± 0.4 
34.0 ± 2.6 
Table 4.28a Clinical Chemistry Results for Study Four - II 
Treatment Control, pH 5.5 2, pH 5.5 10, pH 5.5 
Glucose a 215 ± 15 231 ± 16 271 ± 40 
BUN a 2.0 ± 0.0 1.2 ± 0.4 1.8 ± 1.0 

















5.1 ± 1.8 
3.1 ± 0.2 
1.2 ± 0.7 
1.9 ± 0.8 
0.8 ± 0.4 
72 ± 42 
4.5 ± 3.2 
9.9 ± 0.2 
8.8 ± 0.8 
144 ± 1.5 
4.4 ± 0.5 
115±2.1 
17.7± 1.9 
15.6 ± 1.8 
14.2 ± 7.3 
49.8 ± 44.4 
0.6 ± 0.6 
4.7 ± 1.4 
3.2 ± 0.2 
1.6 ± 0.1 
1.6 ± 0.1 
1.0 ± 0.1 
68 ± 30 
4.0 ± 1.9 
10.1 ± 0.5 
7.4 ± 1.0 
145 ± 1.9 
3.7 ± 0.2 
114±2.6 
18.0 ± 1.6 
16.7 ± 1.5 
4.2 ± 2.6 
25.2 ± 14.4 
0.8 ± 0.4 
Reported as mean ± standard deviation 
5.7±2.1 
3.4 ± 0.2 
1.7 ± 0.2 
1.7 ± 0.2 
1.0 ± 0.2 
83 ± 87 
4.9 ± 5.1 
10.5 ± 0.9 
8.8 ± 2.8 
145 ± 2.9 
5.1 ± 2.4 
114±3.6 
16.6 ± 4.2 
19.5 ± 7.2 
7.0 ± 4.9 
41.5 ± 37.7 
1.0 ± 0.0 
50, pH 5.5 
204 ± 17 
2.0 ± 0.7 
4.9 ± 1.4 
3.2 ± 0.3 
1.5 ± 0.3 
1.7 ± 0.3 
0.9 ± 0.2 
84 ± 56 
3.2 ± 2.7 
10.2 ± 0.3 
8.3 ± 1.0 
145 ± 1.7 
4.0 ± 0.7 
114±3.1 
16.4± 1.7 
18.4 ± 1.5 
51.0 +86. 7 
25.4 ± 9.2 
0.2 ± 0.5 
250, pH 5.5 
203 ± 34 
1.8 ± 1.2 
6.5 ±5.6 
2.1 ± 0.7 
0.9 ± 0.4 
1.2 ±0.4 
0.8 ± 0.1 
70 ± 24 
4.9 ± 3.3 
8.1 ± 4.1 
8.9 ± 2.5 
144 ± 4.0 
6.1 +4.3 
115±1.l 
16.6 ± 1.7 
13.7 ± 3.1 
5.5 ± 4.3 
18.5 ± 13.0 
0.2 ± 0.4 
Bold number are significantly different from control (ANOVA, Tukey's test, p < 0.001, a= 0.05) 
a Units are mg/di 
b Units are g/dl 
c Units are IU/L 
d Units are meq/L 
Table 4.28b Hematology Results for Study Four - II 
Treatment Control, pH 5.5 2, pH 5.5 10, pH 5.5 50, pH 5.5 250, pH 5.5 
WBC a 6.2 ± 0.5 7.5 ± 1.8 12.7 ± 7.3 4.6 ± 1.7 11.0±3.6 
Heterophils a 3.9± 1.1 3.3 ± 1.0 4.2 ± 2.8 2.6 ± 1.0 5.8 ±2.6 
Lymphocytes a 1.9±1.1 3.3 ± 1.6 7.2 ± 8.3 1.4 ± 0.7 4.5 ± 1.8 
Monocyte a 0.3 ± 0.3 0.5 ± 0.3 0.6 ± 0.4 0.3 ± 0.2 0.6 ± 0.3 
Eosinophil a 0.2 ± 0.1 0.5 ± 0.6 0.5 ± 0.4 0.5 ± 0.0 0.7 ± 0.0 
Basophil a 0.2 ± 0.1 0.2 ± 0.2 0.4 ± 0.2 0.1±0.1 0.3 ± 0.2 
Proteinb 4.3 ± 0.6 4.1 ± 0.2 4.2 ± 0.2 3.9 ± 0.5 2.8 ± 0.8 
PCV (%) 34.3 ± 2.8 37.4 ± 1.8 40.5 ± 3.6 29.0 ± 6.6 30.0 ± 6.9 
Reported as mean ± standard deviation 
a units * 103 /µI 
b units g/dl 
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Table 4.29a Clinical Chemistry Results for Study Four - Ill 
Treatment Control, pH 6.5 50, pH 6.5 
Glucose a 192±16 235± 19 
BUN a 
Uric Acid a 
















2.0 ± 0.7 
4.4 ± 1.6 
3.2 ± 0.2 
1.6 ± 0.2 
1.6 ± 0.1 
1.0 ± 0.1 
78 ± 38 
4.1 ± 2.4 
10.1 ± 0.5 
8.7 ± 1.3 
144 ± 2.5 




17.6 ± 22.9 
20.0 ± 18.6 
0.6 ± 0.6 
Reported as mean ± standard deviation 
a Units are mg/di 
b Units are g/dl 
c Units are IU/L 
d Units are meq/L 
1.5 ± 0.8 
3.5 ± 1.0 
3.1 ± 0.1 
1.5 ± 0.1 
1.5 ± 0.1 
1.0 ± 0.2 
63 ± 49 
2.8 ± 1.5 
9.8 ± 0.4 
7.6 ±0.8 
146 ± 2.6 
3.6 ±0.5 
114±3.1 
18.1 ± 2. 1 
17.3±1.6 
5.5 ± 4.3 
18.8± 11.4 
0.7 ± 0.5 
Table 4.29b Hematology Results for Study Four - Ill 
Treatment Control, pH 6.5 50, pH 6.5 








3.2 ± 1.3 
8.0 ± 2.5 
0.5 ± 0.4 
0.7 ± 0.0 
0.1 ± 0.0 
4.0 ± 0.3 
37.3 ± 1.2 
Reported as mean ± standard deviation 
a units * I o3 /µI 
b units g/dl 
3.3 ± 1.4 
9.1±3.8 
0.3 ± 0.2 
0.8 ± 0.7 
0.1±0.1 
4.2 ± 0.4 
37.5 ± 6.6 
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4.4.4 Histopathology Results for Study Four 
An increased frequency of liver lesions was observed in both the 10 and 250 mg Cu/L 
treatment groups, but not in the 50 mg Cu/L treatment group at pH 5.5 (Table 4.30). 
Abnormal pigmentation of hepatic macrophages was observed in three birds that wefe 
exposed to 250 mg Cu/Lat both pH 4.5 and pH 5.5. One bird from each of the high dose 
groups presented with green-brown lipofuscin-type pigments in their sinusoidal 
macrophages and a second bird from the 250 mg Cu/L pH 5.5 treatment group had darker 
and larger brown hemosiderin-type granules. Lipofuscin is the presence of pigmented 
residues from lysosomal digestion and hemosiderin is an insoluble protein produced by 
phagocytic digestion of hematin (Trump, 1980). The mallard which appear to have 
hepatic hemosiderin was also the bird with exceptionally large concentrations of copper 
in its liver and kidney. This individual also displayed several abnormal plasma chemistry 
results including decreased glucose, increased BUN, increased uric acid, and decreased 
protein levels (total, albumin, and globulin). 
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Table 4.30 Frequency of Tissue Lesions in Study Four 
Treatment pH Liver lesion Kidney lesion Ventriculus lesion 
Control 4.5 1/6 a 1/6 NSL6 
2 4.5 NSL NSL NSL 
10 4.5 1/6 1/6 NSL 
50 4.5 NSL NSL NSL 
250 4.5 1/6 1/6 2/6 
Control 5.5 NSL 1/5 NSL 
2 5.5 NSL 2/6 NSL 
10 5.5 3/6 NSL NSL 
50 5.5 NSL NSL NSL 
250 5.5 4/6 NSL 1/6 
Control 6.5 2/6 NSL NSL 
50 6.5 1/6 NSL NSL 
a Number of affected individuals / group's total size 
b No Significant Lesions 
4.4.5 Hepatic Metallothionein Concentrations in Study Four 
Hepatic concentrations of metallothionein were evaluated for the pH 4.5 treatment 
groups. Only samples from the pH 4.5 treatment group were analyzed because of the 
time-intensive nature of the assay. Samples were analyzed for both the total and the 
copper bound fraction of metallothionein. Both fractions was significantly increased (p < 
0.001) in the 250 mg Cu/L treatment group when compared to all other treatment groups 
(Table 4.31). The percentage of copper bound metallothionein was highest in the control 
group. 
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Table 4.31 Hepatic Metallothionein Concentrations in Study Four 
Treatment pH N Cu Total Copper-
(mg Cu/L) metallothionein metallothionein bound 
(µg Cu/g protein) (µg Cu/g protein) (%) 
0 4.5 6 2.25 ± 0.87 a 2.36 ± 0.37 a 95 b 
2 4.5 7 2.15 ± 0.37 3.38 ± 0.46 64 
10 4.5 6 2.57 ± 0.91 2.22 ± 0.62 72 
50 4.5 7 2.04 ± 0.49 2.82 ± 0.63 72 
250 4.5 6 3.48 ± 0.61 C 4.39 ± 0.83 C 79 
a Mean ± standard deviation 
b Calculated by the mean Cu - MT/ mean T - MT 
c Significantly different from all other treatment groups (ANOVA, Tukey's test, p < 
0.001) 
4.5 Study Five 
In Study Five, juvenile mallards were exposed to copper in soft reconstituted water for 
14 days starting on the third and fourth days post-hatch. Measured water pH and copper 
concentrations are summarized in Table 4.32. 
Table 4.32 Water pH and Copper Concentrations (mg Cu/L) in Study Five 
Nominal pH pH range 
(mg Cu/L) 
Control 3.5 3.2 - 3.6 
117 3.5 3.3 - 3.6 
Control 4.0 3.9 - 4.2 
117 4.0 4.0 - 4.4 
117 4.5 4.2 - 4.7 
184 4.5 4.4 - 4.8 
• Below detection limit (0. 1 mg Cu/L) 
b Mean ± standard deviation 
67 














4.5.1 Weight Gain and Consumption Rate in Study Five 
Weight gain was significantly reduced (p < 0.05) in all of the copper treatment groups, 
and the pH 3.5 control group when compared to the pH 4.0 control group (Table 4.33). 
Weight gain in the pH 4.5 treatment groups was compared to the pH 4.0 control group 
because there was no pH 4.5 control group. The 117 pH 3.5 treatment group was 
compared to the 4.0 control group because the pH 3.5 control group demonstrated a 
significant reduction (p < 0.001) in weight gain. There was not a significant difference in 
weight gain between the pH 3.0 control and the 117 mg Cu/L pH 3.0 treatment group. 
There were no significant differences (p > 0.05) among group feed or water consumption 
rat 
Table 4.33 Weight Gain in Study Five 
Treatment (mg Cu/L) pH N Starting Weight (g) 
Control 3.5 7 57.3 ± 4.3 









a Mean ± standard deviation 
7 64.7 ± 7.1 
7 61.7±7.9 
8 61.3 ± 4.5 
7 58.3 ± 5.1 
Weight gain (g) 
174.7±19.3 3 
189.3 ± 35.2b 
240.1 ± 34.1 
182.0 ± 28.1 b 
196.2 ± 53 .9b 
65.2 ± 37.0 cd 
b Significantly different from control pH 4.0 (ANOVA, Tukey's test, p < 0.05) 
c Significantly different from control pH 4.0 (ANOVA, Tukey ' s test, p < 0.001 ) 
d Significantly different from 115 pH 4.5 (ANOVA, Tukey' s test, p < 0.001) 
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Table 4.34 Feed and Water Consumption Rates for Study Five 
Treatment pH Feed Water 
(mg Cu/L) (gig BW/d) (gig BW/d) 
Control 3.5 0.20 ± 0.128 2.28 ± 0.97a 
117 3.5 0.22±0.06 1.72±0.46 
Control 4.0 0.16 ± 0.09 1.32 ± 0.46 
117 4.0 0.21 ± 0.03 1.39 ± 0.63 
117 4.5 0.19 ± 0.05 1.34 ± 0.42 
184 4.5 0.15 ± 0.03 2.19 ± 1.03 
8 Mean ± standard deviation for 12 observations 
4.5.2 Tissue Copper Concentrations in Study Five 
All copper treatment groups had liver copper concentrations that were significantly 
greater than their respective control group (p < 0.001 ). One individual in the 184 mg 
Cu/L treatment group had an extremely elevated concentration of liver copper, 9280 µg 
Cu/g DW. When the mean hepatic copper concentrations were calculated, the individual 
with the largest hepatic copper concentration was excluded because it appears to be an 
outlier (i.e., more than 4 standard deviations above the mean) (Kleinbaum, 1988). The 
mean liver copper concentration for the 184 mg Cu/L treatment group at pH 4.5 was 
significantly greater (p <0.001), almost 50% higher, than the mean for the 117 mg Cu/L 
treatment group at pH 4.5 (Table 4.35). Mallards in the 117 mg Cu/L treatment group at 
pH 4.5 had significantly greater (p < 0.001) liver copper concentrations when compared 
to the 117 mg Cu/L treatment groups at either pH 3.5 or 4.0, suggesting that hepatic 
copper accumulation is reduced as drinking water pH decreases. 
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Table 4.35 Liver Copper Concentrations in Study Five 
Treatment pH N Liver Copper Range 
(mg Cu/L) (µg Cu/gDW) (µg Cu/gDW) 
Control 3.5 7 188.5 ± 41.6 136.2 - 255.8 
117 3.5 7 918.1 ± 381.8b 311.0 - 1309.6 
Control 4.0 7 357.6 ± 138.5 177.6 - 512.7 
117 4.0 7 726.4 ± 282.0c 220.4 - 1020.1 
117 4.5 8 1276.4 ± 568.6c 851.7 - 2569.3 
184 4.5 7 2346.8 ± 965.1 cde 1183.0 - 4029.4 
b Mean ± standard deviation 
Significantly different from pH 3.5 control (ANOVA, Tukey's test, p < 0.001) 
~ Significantly different from pH 4.0 control (ANOVA, Tukey's test, p < 0.001) 
Significantly different from 117 mg Cu/L pH 4.5 (ANOVA, Tukey' s test, p < 0.001) 
e An outlier, with 9280 µg Cu/g, was excluded from the mean. The mean ± standard deviation 
including the outlier is 3646. 7 ± 2670.0. 
The mean kidney copper concentration in the 184 mg Cu/L pH 4.5 treatment group 
was significantly greater (p < 0.001) than the mean for the pH 4.0 control group (Table 
4.36). No kidney copper value was available for the individual that was considered an 
outlier because of its elevated liver copper concentration and consequently it is not 
included in the mean. 
Table 4.36 Kidney Copper Concentrations in Study Five 
Treatment pH N Kidney Copper Range 
(mg Cu/L) (µg Cu/g) (µg Cu/g) 
Control 3.5 6 3.5 ± 0.4a 3.1 - 4.2 
117 3.5 7 6.4 ± 3.0 4.2 - 12.2 
Control 4.0 7 4.2 ± 0.6 3.5 - 5.0 
11 7 4.0 7 5.0 ± 1.2 3.7 - 6.6 
117 4.5 8 5.0 ± 1.1 3.9 - 6.7 
184 4.5 5 10.4 ± 5.2b 4.2-16.5 
b Mean ± standard deviation 
Significantly different from pH 4.0 control (AN OVA, Tukey's test, p < 0.001) 
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The mean feather copper concentration for the 184 mg Cu/L, pH 4.5, treatment group 
was significantly greater (p < 0.001) than all other treatment groups (Table 4.37). The 
individual in the 184 mg Cu/L treatment group with an exceptionally large hepatic copper 
concentration reported the lowest feather copper concentration in its treatment group, i3 
µg Cu/g. Feather copper concentrations were significantly elevated in all of the 117 mg 
Cu/L treatment groups when compared to the pH 4.0 control group. The 117 mg Cu/L 
treatment group at pH 4.5 had significantly greater feather copper concentrations than 
either the 117 mg Cu/Lat pH 3.5 or 4.0. 
Table 4.37 Feather Copper Concentrations in Study Five 
Treatment pH N Feather Copper (µg /g) Range (µg /g) 
(mg Cu/L) 
Control 3.5 7 23.6± 19.5 10.4 - 62.9 
117 3.5 7 37.3 ± 14.7b 13.1 - 53.0 
Control 4.0 7 7.7 ± 1.7 5.4- 10.2 
117 4.0 7 49.9± 12.0c 31.6 - 70.2 
117 4.5 8 73 .7 ± 22.6 cd 43 .7 - 105.0 
184 4.5 7 107.6 ± 40.6 cd 31.0 - 168.0 
a Mean ± standard deviation 
b Significantly different from control pH 3.5 (ANOVA, Tukey's test, p < 0.001) 
c Significantly different from control pH 4.0 (ANOVA, Tukey's test, p < 0.001) 
d Significantly different from 117 mg Cu/L pH 4.0 (ANOVA, Tukey ' s test, p < 0.001) 
4.5.3 Clinical Chemistry Results for Study Five 
Mallards treated with 117 mg Cu/L at pH 4.0 and pH 3.5 had mean bicarbonate and 
anion gap values that were significantly different (p < 0.001) than the pH 4.0 control 
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Table 4.38a Clinical Chemistry Results for Study Five - I 
Parameter Control, pH 3.5 117, pH 3.5 
Glucose a 198.2 ± 9.3 216.0 ± 5.4 
Bun a 1.3 ± 0.8 1.3 ± 0.5 
Uric acid a 3.2 ± 1.0 4.4 ± 1.2 
Total protein b 2.9 ± 0.2 3.2 ± 0.8 
Albumin b 1.4 ± 0.2 1.5 ± 0.6 
Globulin b 1.5 ± 0.1 1.6 ± 0.3 
AIG 0.9 ± 0.1 0.9 ± 0.1 
ASTC 54.1 ± 49.2 29.2 ± 23.3 
CKc• 4.2 ± 5.1 I.I± 0.4 
Calcium d 10.0 ± 0.3 10.2 ± 0.8 
pd 8.1 ± 1.0 7.2 ± 1.0 
Nad 145.7 ± 4.2 142.7 ± 3.3 
K d 4.2 ± 0.8 3.6 ±0.3 
Cl d 115.4 ± 1.9 112.3 ± 2.6 
Bicarbonate d 17.7±1.9 20.1 + 1.7 
Anion gap 16.9 ± 16.8 13.8 + 1.9 
Lipemia a 10.6 ± 10.9 2.7 ± 3.4 
Hemolysis a 25.0 ± 22.3 16.7 ± 10.0 
Icterus a 0.6 ±0.5 0.8 ± 0.4 
Creatine b 1.06 ± 0.6 2.22±1.4 
Reported as mean ± standard deviation 
Bold number are significantly different from the respective control group (ANOV A, Tukey's test, 
p<0.001) 
• Units are mg/di 
b Units are g/dl 
c Units are IU/L (* CK units are * I 000) 
d Units are meq/L 
Table 4.38b Hematology Results for Study Five - I 
Parameter Control, pH 3.5 117, pH 3.5 
WBC 11.2±6.1 17.0± 14.7 





P . b rotem 
PCV (%) 
5.2 ± 3.6 
0.3 ± 0.1 
0.1 ± 0.1 
0.4 ± 0.2 
4.0 ± 0.7 
34.3 ± 2.3 
Reported as mean ± standard deviation 
• units* 103/µl 
bUnits g/dl 
6.6 ± 3.8 
1.3 ± 2.3 
0.5 ± 0.5 
0.6 ± 0.6 
4.1 ± 0.7 
35.9 ± 2.1 
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Table 4.39a Clinical Chemistry Results for Study Five - II 
Parameter Control, pH 4.0 117, pH 4.0 
Glucose a 200.1 ± 26.3 204.0 ± 10.9 
Bun a 2.0 ± 1.0 1.1±0.4 
Uric acid a 6.5 ± 3.4 4.4 ± I.I 
Total protein b 3.2 ± 0.3 3.1 ± 0.3 
Albumin b 1.7 ± 0.2 1.6 ± 0.1 
Globulin b 1.5 ± 0.2 1.6 ± 0.2 
A/G I.I ±0.19 1.0 ± 0.1 
ASr 80.4 ± 68.5 41.0 ± 35.9 
CK' . 3.1±2.4 2.4 ± 2.2 
Calcium ct 10.4 ± 0.5 10.1 ± 0.3 
pd 10.2 ± 3.5 7.4 ± 0.6 
Nact 144.1 ± 3.9 142.7 ± 2.4 
Kd 4.4 ± 0.8 3.8 ± 0.1 
Cl d 113.1±3.4 113.0 ± 2.4 
Bicarbonate ct 14.8 ± 4.8 20.2 + 1.0 
Anion gap 21.3 ± 8.4 13.3 + 1.8 
Lipemia a 13.2 ± 16.7 5.1 ± 3.7 
Hemolysis a 41.0 ± 44.3 22.8 ± 11.8 
Icterus a 0.7 ± 0.5 0.4 ± 0.5 
Creatine ct 1.1 7±0.4 1.65±1.1 
Reported as mean ± standard deviation 
Bold number are significantly different from the respective control group (ANOV A, Tukey's test, p<0.05) 
\Jnits are mg/di 
b Units are g/dl 
c Units are IU/L (* CK units are * I 000) 
d Units are meq/L 
Table 4.39b Hematology Results for Study Five - II 
Parameter Control, pH 4.0 117, pH 4.0 
WBC3 11.2 ± 4.7 7.4 ± 3.4 





Plasma Protein b 
PCV (%) 
6.1 ± 3.6 
0.4 ± 0.2 
0.1 ± 0.0 
0.4 ± 0.2 
3.9 ± 0.4 
37.3 ± 3.6 
Reported as mean ± standard deviation 
• Units * 103/µI 
b Units g/dl 
2.9 ± 1.4 
0.3 ± 0.1 
0.3 ± 0.3 
0.3 ± 0.3 
4.0 ± 0.3 
37.1 ± 1.8 
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Table 4.40a Clinical Chemistry Results for Study Five - Ill 
Parameter 117, pH 4.5 184, pH 4.5 
Glucose a 218.0 ± 15.5 205.2 ± 13.6 
Bun a 1.5 ± 1. 1 2.2 ± 1.0 
Uric acid a 5.2 ± 1.6 4.3 ±2.0 
Total protein b 3.0±0.3 2.8 ± 0.2 
Albumin b 1.6 ± 0.2 1.5 ± 0.2 
Globulin b 1.4 ± 0.3 1.3 ± 0.2 
A/G I. I± 0.1 I.I± 0.3 
AST" 44.4 ± 55.3 43.3 ± 27.3 
CKc• 2.4±3.1 2.6 ± 1.9 
Calcium a 9.7 ± 0.7 9.3 ± 0.2 
pd 7.1 ± 0.9 6.8 ± 0.7 
Nact 143.0 ± 3.3 143.0 ± 1.8 
Kd 4.5 ± I.I 3.9 ± 0.5 
Cl d 144.0 ± 4.3 11 5.2 ± 1.9 
Bicarbonate ct 16.8 ± 2.2 17. 1 ±1.5 
Anion gap 16.9 ± 2.6 14.5±2. 1 
Lipemia a 12.4 ± 9.5 14.1 ± 2.6 
Hemolysis a 45.3 ± 51 22.5 ± 18.8 
Icterus a 0.6 ± 0.5 0.0 ± 0 
Creatine b 2.33 ± 1.3 1.67 ± 0.7 
Reported as mean ± standard deviation 
Bold number are significantly different from the respective control group (ANOV A, Tukey's test, p<0.05) 
'\Jnits are mg/di 
b Units are g/dl 
c Units are IU/L (* CK units are * I 000) 
d Units are meq/L 
Table 4.40b Hematology Results for Study Five - Ill 
Parameter 117, pH 4.5 184, pH 4.5 
WBca 8.7 ± 3.3 8.3 ± 5.6 





Plasma Protein b 
PCV (%) 
5.0 ± 1.8 
0.5 ± 0.4 
0.4 ± 0.3 
0.1±0.1 
4.1 ± 0.4 
34.0 ± 7.0 
Reported as mean ± standard deviation 
• Units * I 03 /µI 
b Units g/dl 
1.8 ± 1.4 
0.3 ± 0.3 
0.3 ± 0.3 
0.1 ± 0.1 
3.8 ± 0.4 
32.4 ± 7.3 
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group (Tables 4.38a, 4.39a). There were no significant differences (p > 0.05) among any 
of the measured hematology parameters (Tables 4.38b, 4.39b, and 4.40b). 
4.5.4 Histopathology Results for Study Five 
Microscopic evaluation of tissues from kidney, liver, and ventriculus demonstrated no 
trend in either the prevalence or types of lesion among treatment groups. No visible 
lesions were observed in any of the kidney samples. All of the ventriculus samples, from 
both treatment and control groups, had some degree of kaolin degeneration (Table 4.41 ). 
A section of intestinal tissue was submitted for the mallard with an exceptionally high 
liver copper concentration because it had an unusual appearance. The pathologist 
observed nodules of necrotic fat spherules, thin connective tissue walls, but no 
inflammation (Nordin, 1997). 
Table 4.41 Frequency of Tissue Lesions in Study Five 
Treatment pH Liver Ventriculus 
(mg Cu/L) lesions lesions 
frequency frequency 
Control 3.5 2/7 5/7a 
117 3.5 3/7 717 
Control 4.0 017 4/7 
117 4.0 017 517 
117 4.5 1/8 6/8 
184 4.5 1/7 4/7 
a Number of affected individuals/ total group size 
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4.5.5 Hepatic Concentrations of Metallothionein in Study Five 
Liver tissue was analyzed for concentrations of both the total and the copper bound 
metallothionein. No significant differences were seen between treatment groups for 
either fraction (Table 4.42). Copper treatment groups contained the largest percentage ef 
copper bound protein. 
Table 4.42 Concentrations of Hepatic Metallothionein in Study Five 
Treatment pH Cu metallothionein Total metallothionein Copper bound 
(mg Cu/L) (µg Cu/g protein) (µg Cu/g protein) (%) 
Control 3.5 0.96 ± 0.393 1.55 ± 0.553 626 
117 3.5 1.45 ± 1.19 1.72 ± 0.13 84 
Control 4.0 1.20 ± 0.73 1.93 ± 0.88 62 
117 4.0 2.21 ± 1.33 2.52 ± 1.65 88 
117 4.5 1.15 ± 0.88 1.43 ± 0.97 80 
184 4.5 1.65 ± 1.55 1.84 ± 1.80 90 
a Mean ± standard deviation 
b Calculated as the mean Cu - MT/ mean T- MT 
4.6 Study Six 
Juvenile mallards were exposed to copper in soft reconstituted water for 34 days 
beginning on the third day post-hatch. The nominal and measured exposure 
concentrations are reported in Table 4.43. 
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Table 4.43 Copper Concentrations in Study Six Treatment Solutions 
Calculated Control 2 River Matrix 50 
(N =4) (mg Cu/L) (N = 4) (N = 4) (N = 4) 
Analyzed BDL a 2.2 ± 0.8 6 1.9 ± 1.0 47.0 ± 4.4 
(mg Cu/L) 
a Below detection limit (0.1 mg Cu/L) 
b Mean ± standard deviation, 
4. 6. 1 Weight Gain and Consumption Rates in Study Six 
Weight gain for the 50 mg Cu/L treatment group was significantly reduced (p <0.001), 
by more than 10%, when compared to the control group (Table 4.44). There were no 
significant differences (p > 0.05) among feed or water consumption rates for any of the 
treatment groups (Table 4.45). 
Table 4.44 Weight Gain in Study Six 
Treatment (mg Cu/L) N Starting Weight (g) 
Control 8 64.8 ± 5.8 
2 8 63.2±4.5 
River matrix (2) 8 59.9 ± 4.5 
50 8 63.6 ± 6.2 
a Mean ± standard deviation 
Weight gain (g) 
778.6 ± 60.3a 
746.3 ± 81.6 
830.2 ± 108.6 
683.0 ± 91.2b 
b Significantly different from control (ANOVA, Tukey's test, p < 0.001) 
Table 4.45 Feed and Water Consumption Rates in Study Six 
Treatment (mg Cu/L) N Feed 
Control 
2 






a Mean ± standard deviation 
(gig BW/d) 
0.42 ± 0.05 
0.38 ± 0.02 
0.41 ± 0.09 





1.06 ± 0.28 
1.15±0.33 
1.44 ± 0.26 
4. 6.2 Tissue Copper Concentrations in Study Six 
There were no significant differences among the liver or kidney copper concentrations 
for any of the treatment groups (Tables 4.46 and 4.47). Mean feather copper 
concentration for the 50 mg Cu/L treatment group was significantly greater (p < 0.05) 
than the control and 2 mg Cu/L treatment group (Table 4.48). 
Table 4.46 Liver Copper Concentrations in Study Six 
Treatment N Liver copper 
(mg Cu/L) (µg Cu/g DW) 
Control 8 456.7± 76.la 
2 8 429.4 ± 174.5 
River matrix (2) 8 472.4 ± 111.8 
50 8 444.8 ± 201.7 
a Mean ± standard deviation 
Table 4.47 Kidney Copper Concentrations in Study Six 
Treatment N Kidney Copper 
(mg Cu/L) (µg Cu/g) 
Control 7 5.2 ± 0.4 
2 8 5.5 ± 1.0 




a Mean ± standard deviation 
5.3 ± 0.6 
6.4 ± 1.3 
Table 4.48 Feather Copper Concentrations for Study Six 
Treatment N Feather Copper 
Control 
2 






a Mean ± standard deviation 
(µg Cu/g) 
10.6 ± 5.0a 
9.9 ± 2.3 
14.6 ± 6.0 
22.8 ± 7.0b 
Range 
(µg Cu/g DW) 
274.1 - 510.9 
236.7 - 777.5 
360. 7 - 660. 7 
192.2 - 786.3 
Range 
(µg Cu/g) 
4.8 - 5.7 
4.1 - 7.6 
4.4 - 6.4 




5.6 - 14.1 
8.8 - 24.5 
16.5 - 36.8 
b Significantly different from the control and 2 mg Cu/L treatment group (ANOV A, 
Tukey's test, p < 0.005) 
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4.6.3. Clinical chemistry Results for Study Six 
No significant differences were observed among the measured plasma chemistry 
results (Tables 4.49). Likewise, there were no significant differences in the measured 
hematology parameters between treatment groups (Table 4.50). 
Table 4.49 Clinical Chemistry Results for Study Six 
Treatment Control 2 
(mg Cu/L) (N = 8) (N = 8) 
Glucosea 199.9 ± 9.3 204.1 ± 22.6 
Bun a 1.6 ± 0.7 1. 1 ± 0.4 
Uric acida 3.9 ± 1.2 4.2 ± 1.6 
Total protein b 3.6 ± 0.3 3.4 ± 0.3 
Albumin b 1.8 ± 0.2 1.7 ± 0. 1 
Globulin b 1.8 ± 0.2 1.7 ± 0.2 
A/G 1.0 ± 0.1 1.0 ± 0. 1 
AST c 55.4 ± 82.6 21.3 ± 7.4 
CK c 3.2 ± 4.0 1.4 ± 0.4 
Calcium a 11.0 ± 0.5 11.0 ± 0.5 
Pa 8.0 ± 2.0 7.8 ± 1.8 
Na d 144.8 ± 2.7 146.1 ± 1.4 
K d 4.7 ± 2.4 4.3 ± 1.3 
Cl d 111.6± 1.4 112.3 ± 1.9 
Bicarbonate d 17. 7 ± 3 .4 18.6 ± 2.8 
Aniongap 21.1± 5.6 19.8 ± 3.2 
Lipemia a 8.0 ± 5.8 13.4 ± 10.1 
Hemolysis a 31.9 ± 20.4 14.4 ± 9.7 
Icterus a 0.9 ± 0.4 0.9 ± 0.4 
Reported as mean ± standard deviation 
a Units are mg/dl 
b Units are g/dl 
c Units are IU/L (*CK units are * l 000) 
d Units are meq/L 
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River 
(N = 8) 
208.2 ± 27.6 
1.3 ± 0.5 
4.2 ± 1.1 
3.4 ± 0.4 
1.7± 0.2 
1.7 ± 0.2 
1.0 ± 0.2 
32.8 ± 15.2 
2.1 ± 1.3 
10.7 ± 0.6 
8.2 ± 0.7 
145.0 ± 2.3 
4.6 ± 1.1 
111.4 ± 1.2 
17.0± 2.6 
21.1± 3.3 
20.5 ± 11.5 
36.0 ± 39.5 
0.9 ± 0.4 
50 
(N = 8) 
208.2 ± 13.9 
1.3 ± 0.5 
4.4 ± 1.3 
3.5 ± 0.3 
1.7 ± 0.2 
1.8 ± 0.2 
0.9 ± 0.1 
35.5 ± 26.1 
2.5 ± 1.9 
10.8 ± 0.5 
7.9 ± 0.8 
143.3 ± 3.3 
4.2 ± 1.6 
111.5 ± 2.2 
18.2 ± 1.4 
18.0 ± 0.9 
6.2 ± 5.0 
30.0 ± 25.8 
1.0 ± 0.0 
Table 4.50 Hematology Results for Study Six 
Treatment Control 2 River 50 
(mg Cu/L) (N =8) (N=8) (N =8) (N = 8) 
WBC 16.4 ± 6.5 a 11.3 ± 4.8 a 14.7 ± 6.0 a 14.5 ± 5.8 a 
Heterophiles 6.8 ± 2.1 4.2 ± 1.8 5.9 ± 1.9 5.3 ± 4.3 
Lymphocyte 8.2 ± 5.5 5.8 ± 3.3 7.8 ± 4.7 7.8 ± 2.2 
Monocytes 0.6 ± 0.2 0.5 ± 0.3 0.4 ± 0.8 0.7 ± 0.3 
Eosinophils 0.4 ± 0.4 0.4 ± 0.2 0.3 ± 0.2 0.5 ± 0.2 
Basophiles 0.6 ± 0.2 0.5 ± 0.4 0.9 ± 0.4 0.7 ± 0.4 
Plasma protein 4.4 ± 0.5 4.0 ± 0.3 4.4 ± 0.4 4.1 ± 0.4 
PCV (%) 36.1 ± 4.5 38.3 ± 3.4 34.1 ± 3.5 36.2 ± 3.5 
a Mean± standard deviation, all units* 103/µl except plasma protein (g/dl) 
4.6.4 Histopathology Results for Study Six 
An increased prevalence of liver lesions was seen in the river matrix and 50 mg Cu/L 
treatment groups (Table 4.51 ). Lesions included hepatocyte vacuolization, and 
pericholangitis. Periductulitis was observed in one bird from the river matrix treatment 
group. Erosion of the kaolin layer associated was noted in nearly all of the ventriculus 
samples regardless of the treatment. 
Table 4.51 Frequency of Tissue Lesions for Study Six 
Treatment Liver lesion 





a Number of affected individuals / total group size 














4. 7 Data Analysis 
In the preceding sections of this chapter the results from each of the individual studies 
are presented separately. In this section, selected results are compared to emphasize 
patterns and trends in the data. 
4. 7. 1 Exposure Concentrations and Dose Calculations 
A fundamental principle of toxicology is the dose-response relationship, which 
correlates biological or physiological effects to known quantities of a test substance. 
Essential to this association is the ability to measure the amount of substance consumed 
by ( or administered to) a test subject. There are two basic approaches to quantifying 
exposure: clinical studies generally measure treatments by dose, which is expressed as 
milligrams of the test substance per kilograms body weight per day (mg/BW kg/d), 
whereas field investigations or other ecologically based studies tend to estimate exposure 
as a function of consumption rate and media concentration. In this section, the measured 
consumption rates and exposure concentrations from the laboratory studies are used to 
calculate an estimated daily dose for each treatment group. 
4.7.1. 1 Feed Consumption 
Feed consumption rates for the control groups from the 14 day studies ranged from 
0.18 - 0.33 gig BW/d with a mean and standard deviation of 0.22 ± 0.01. Feed 
consumption rates for the control groups from the 34 day studies ranged from 0.07 - 0.32 
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gig BW/d with a mean and standard deviation of 0. I 7 ± 0.6. Feed consumption rates 
between the 14 day and 34 day studies were not significantly different (p > 0.05). The 
feed consumption rate calculated from 52 observations of control groups in both the 14 
day and 34 day studies was 0.18 ± 0.06 gig BW/d. Exposure to a range of copp~r 
concentrations did not appear to influence consumption rates, even in treatment groups in 
which weight gain was reduced by more than 50% (Tables 4.22 and 4.34). Likewise, 
feed consumption was not reduced in mallards that demonstrated reduced weight gain 
when provided with drinking water at pH 3.5 (Table 4.34). The mean feed consumption 
rate for all treatment groups, based on 166 observations was 0.20 ± 0.05 gig BW/d. 
4.7.1.2 Water Consumption 
Drinking water consumption rates for the control groups in both the 14 and 34 day 
studies ranged from 0.7 - 2.8 ml/g BW/d with a mean± standard deviation of 1.1 ± 0.1 
ml/g BW/d (N = 36). Elevated but not significantly different mean water consumption 
rates were observed in the pH 3.0 and 3.5 control groups; mean and standard deviation of 
2.0 ± 0.5 (N = 3) and 2.3 ± 1.0 (N = 3) respectively. The mean water consumption rate 
for all treatment groups was 1.3 ± 0.1 ml/g BW/d (N = 103). 
4.7.1.3 Estimated Copper Dose 
Copper doses were calculated for each treatment group by multiplying the measured 
concentrations of copper in the treatment media by the mean consumption rate (Table 
4.52). Because of the uncertainty associated with the dose calculation all of the values 
were rounded to two significant digits. The estimated dose from untreated feed was 5 mg 
Cu/kg BW/d (i.e., all control groups), based on the measured concentration of copper. 
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Table 4.52 Estimated Copper Dose 
Study Treatment/ pH Feed Feed 
Nominal Copper a Dose be 
1 Low 219 40 
Medium 420 80 
High 1027 210 
2 Acetate 1025 210 
Sulfate 503 100 
3 600d 3.0 26 5 
600 4.7 26 5 
1200 4.7 5 
4 2 4.5 26 5 
10 4.5 26 5 
50 4.5 26 5 
250 4.5 26 5 
2 5.5 26 5 
10 5.5 26 5 
50 5.5 26 5 
250 5.5 26 5 
50 6.5 26 5 
5 117 3.5 26 5 
117 4.0 26 5 
117 4.5 26 5 
184 4.5 26 5 
6 2 4.5 26 5 
River 4.5 26 5 
50 4.5 26 5 
• Units are mg Cu/kg 
b Units are mg Cu/kg BW/d 
c Feed copper concentration multiplied by 0.2 g/kg BW 
d Units are mg Cu/L 
• Water copper concentration multiplied by 1.3 ml/kg BW 
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Water Water Total 
Copper d Dose be Dose b 
< 1 < 1 40 
< 1 <1 90 
< 1 < 1 210 
. 
< 1 < 1 210 
< 1 < 1 100 
605 790 800 
607 790 800 
1195 1550 1600 
2 5 10 
10 20 20 
52 70 70 
252 330 340 
2 5 10 
10 10 20 
49 60 70 
250 325 330 
52 73 80 
115 150 160 
116 151 160 
116 154 160 
189 246 250 
2 3 10 
2 3 10 
47 61 70 
4. 7.2 Weight Gain 
Weight gain is one of the most common methods for evaluating treatment toxicity. 
Reduced weight gain was calculated as the percent reduction in weight gain between the 
treatment and control groups using the following equation: 
Percent reduction in weight gain = 
[1- (weight gain treatment group/weight gain control group)] x JOO 
The weight gain results from Studies One and Two are combined in Figure 4.1 . 
Weight gain was significantly correlated with copper dose (p < 0.001, R2 = 0.99). The 
association is described by the following equation: 
y = -0.0578x - 3.1907 
Weight gain was significantly decreased (p < 0.001) in mallards with dietary exposure 
to 90 mg Cu/kg BW/d or greater when compared to the respective control groups (Figure 
4.1). Weight gain was decreased by 8 to 15% in mallards that received between 90 and 
210 mg Cu/kg BW/d. One notable exception to this trend of decreasing weight gain with 
increasing dietary copper exposure was the copper acetate treatment group, which 
received a dose of 210 µg Cu/g BW/d without a reduction in weight gain (Figure 4.1). 
The same dose of dietary copper as copper sulfate, 210 µg Cu/g BW/d, reduced mean 
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Figure 4.1 Reduced Weight Gain with Dietary Exposure to Copper for 34 Days 
* -Significantly different from respective controls (ANOV A, Tukey's test, p < 0.00 I) 
The weight gain results from Studies Four and Five are combined in Figure 4.2. 
Significantly decreased weight gain was observed in mallards with drinking water 
exposures between 60 and 160 mg Cu/kg BW/d when compared to the respective control 
groups. Weight gain in mallards that received between 60 and 160 mg Cu/kg BW/d w~s 
moderately decreased (10 to 20%). In contrast, weight gain was reduced by more than 
50% in mallards that were exposed to doses of copper greater than or equal to 250 mg 
Cu/kg BW/d. The considerable difference in weight gain reduction between mallards that 
received 160 mg Cu/kg BW/d and those that received 250 mg/kg BW/d suggests that 
there may be an effect threshold at an exposure level above 160 mg Cu/kg BW/d. 
The weight gain for mallards in both the drinking water and dietary exposures at 10 
days post-hatch (Studies One, Two, Four and Five and Six) are combined in Figure 4.3. 
Study Three was excluded from this comparison because the short duration of the study. 
There was no apparent difference in weight gain between the drinking water and dietary 
treatment groups that received comparable doses of copper. 
4. 7.3 Tissue Copper 
One of the main objectives for the laboratory investigation was to determine a suitable 
method for evaluating copper exposure in juvenile mallards. Copper concentrations in 
several tissues were evaluated for their potential as biological indicators, or biomarkers, 
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Figure 4.2 Reduced Weight Gain with Drinking Water Exposure to Copper for 14 Days 
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Figure 4.3 Comparison of Body Weight Between 34 Day Dietary and 14 Day 
Drinking Water Studies 
* -Significantly diferent from respective control group (ANOV A, Tukey's test, p < 0.001) 
4.7.3.1 Liver Copper 
Liver copper concentrations in untreated birds from the 34 day dietary studies ranged 
from 138 to 713 µg/g DW. Liver copper results from Studies One and Two are combined 
in Figure 4.4. The copper acetate treatment group was the only dietary treatment group 
with significantly (p < 0.05) elevated hepatic copper concentrations (Figure 4.4). Liver 
copper concentrations in the dietary copper acetate treatment group were significantly 
greater (p < 0.05) when compared to the dietary copper sulfate group which received the 
same dose of copper (Table 4.53) suggesting that copper acetate may have an increased 
absorption rate. 
Table 4.53 Liver Copper Concentrations Following Exposure to Dietary Copper 
Sulfate and Copper Acetate 
Treatment 
Acetate (Study 2) 
Sulfate (Study 1) 
a Mean ± standard deviation 
Estimated Copper Dose 
(mg Cu/kg BW/d) 
210 
210 
b Estimated dry weight based on 72.5% moisture 
Liver Copper 
(µg Cu/g DW) 
1282 ± 475 ab 
668 ± 197 C 
c Significantly different from the acetate treatment groups, ANOV A and Tukey's test, p < 
0.05 
Liver copper concentrations in untreated birds from the 14 day drinking water studies 
ranged from 85 - 555 µg/g DW. Liver copper results from Studies Four and Five are 
combined in Figure 4.5. Hepatic copper concentrations were significantly increased in 
mallards that received a dose greater than or equal to 160 mg Cu/kg BW/d (Figure 4.5). 
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Figure 4.4 Liver Copper Accumulation with Dietary Exposure for 34 Days 
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Figure 4.5 Liver Copper Accumulation with Drinking Water Exposure for 14 Days 
• -Significantly different from respective control (ANOV A, Tukey's test, p < 0.05) 
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mallards that were exposed to larger doses of copper had lower liver copper 
concentrations. 
Two of the birds that received large doses of copper, 250 and 330 mg Cu/kg BW, 
accumulated substantial concentrations of copper in their livers (identified as High 
Copper or HC in Figure 4.5). The liver copper concentrations in these two individuals 
were three to four times greater than other birds that received the same dose of copper. 
Because the hepatic copper concentrations in these birds were more than four standard 
deviations above the mean they were treated as outliers, removed from the data set and 
the mean was recalculated (Tables 4.23 and 4.35). 
4.7.3.2 Kidney Copper 
Kidney copper concentrations in untreated birds ranged from 2.74 - 4.96 µg Cu/g DW 
in the 14 day studies and 4.82 - 5.71 µg Cu/g DW in a 34 day study. Renal copper 
concentrations were significantly increased (p < 0.001) in mallards that received 250 mg 
Cu/kg BW /d or greater (Figure 4.6). One of the birds with exceptionally large hepatic 
copper concentrations (Figure 4.5) also had a substantially increased kidney copper 
concentration. Because the kidney copper concentration for this bird was more then four 
standard deviations greater than the mean it was omitted from the mean. Unfortunately, 
no kidney copper data was obtained for the second mallard with extremely large hepatic 
copper concentration because the entire kidney sample was accidentally fixed in 10% 
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Figure 4.6 Kidney Copper Accumulation with Drinking Water Exposure for 14 Days 
• -Significantly diferent from respective control group (ANOV A, Tukey's test, p < 0.05) 
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4.7.3.3 Feather Copper 
Feather copper concentrations in untreated birds ranged from 2.1 - 32.2 µg Cu/g in the 
34 day studies. Feather copper results from Studies One and Two are combined in Figure 
4.7. Significantly increased feather copper concentrations were observed in mallards that 
received a dietary dose of 90 mg Cu/kg BW/d or greater. Feather copper concentrations 
were significantly correlated (R2 = 0.99, p < 0.001) with dietary copper treatment. The 
association between dietary treatment and feather copper accumulation is described with 
the equation: 
Feather Copper Concentration = 0.28 (Dose of Dietary Copper) + 14. 71 
Feather copper concentration in untreated birds ranged from 5 .4 - 22.1 µg Cu/ g in the 
14 day drinking water studies. Feather copper results from Studies Four and Five are 
combined in Figure 4.8. Significantly increased feather copper concentrations were 
observed in mallards that received a drinking water dose of 160 µg Cu/kg BW/d or 
greater. Feather copper concentrations in the pH 4.5 treatment groups appeared to reach 
a peak at dose of 250 mg Cu/kg BW/d; mallards that were exposed to larger doses of 
copper had lower feather copper concentrations. Feather copper concentrations were 
significantly correlated (R2 = 0.76, p < 0.001) with drinking water exposure. The 
association between drinking water treatment and feather copper accumulation is 
described with the equation: 






-~ 50 u 
00 
:i -.. g_ 40 







50 100 150 
Copper Dose (mg Cu/kg BW/d) 
* 
y = 0.26x + 17.4 
R2 = 0.86 
p < 0.001 
200 
Figure 4.7 Feather Copper Accumulation with Dietary Exposure for 34 Days 
• - Significantly different from control (ANOV A, Tukey's test, p < 0.05) 
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Figure 4.8 Feather Copper Accumulation with Drinking Water Exposure for 14 Days 
• -Significantly different from respective control (ANOVA, Tukey's test, p <0.05) 
Drinking water pH was negatively associated with feather copper accumulation (Figure 
4.9). Feather copper concentration were significantly increased in the 50, 117, and 250 
mg Cu/L treatment groups when compared to a respective control group and there were 
significant differences between the various pH exposure at all three treatment levels. The 
significant difference between feather copper concentrations for treatment groups that 
received the same copper concentrations at different drinking water pH suggest that 
feather copper accumulation is reduced when the metal is present in acidic water. 
4.7.3.4 Association Between Feather Copper and Liver Copper Concentrations 
Both liver and feather copper concentrations were significantly elevated in mallards 
that were exposed to large doses of copper in their drinking water for 14 days (Figures 
4.5 and 4.8). Figure 4.10 depicts the association between the natural log (In) liver and In 
feather copper concentrations for individual birds. There is a significant correlation (p < 
0.001, R2 = 0.34) between In feather and In liver copper concentrations. The following 
equation describes the association between liver copper and feather copper: 
lny = 0.51 lnx + 0.27 
Copper measurements in feather samples could represent a non-lethal approach for 











\0 .... <I) 
00 -5 100 Contains data <tl 
<I) 
from Study Four µ. 
* and Study Five. * Bars represent 
group means+/-
50 SD (N = 5-8). 
0 
Control 2 10 50 117 250 
Copper Treatment (mg Cu/L) 
Figure 4.9 The Influence of Drinking Water pH on Feather Copper Accumulation 
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Figure 4.10 Liver Copper and Feather Copper Accumulation in individuals from the 14 Day 
Drinking Water Studies 
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4. 7.4 Tissue Copper Concentrations and Treatment Effects 
Tissue copper concentrations were significantly increased in mallards that were 
exposed to elevated concentrations of copper (Figures 4.5 , 4.6, 4.7, and 4.8). Likewise, 
weight gain was significantly reduced in mallards that received large dose of copper 
(Figures 4.1, and 4.2). This section examines the association between the biological 
measurement of exposure and the biological measurements of treatment toxicity. 
Figure 4.11 demonstrates that there is a significant (p < 0.001) correlation (R2 = 0.53) 
between weight gain and liver copper concentrations for individual birds. The 
relationship between weight gain and liver copper accumulation is described with the 
following equation: 
y = -0. 0729x+ 263.1 
The individuals that were considered as high copper accumulators were excluded from 
this regression analysis. 
Figure 4.12 demonstrated that there is also a significant association between weight 
gain and feather copper concentration (p < 0.001). The following equation describes the 
relationship between weight gain and feather copper accumulation: 
y = -0.679Jx + 262.86 
The correlation coefficient (R2 = 0.21) for feather copper and weight gam 1s 
substantially lower than the correlation coefficient for liver copper and weight gain (R2 = 
0.53). Because liver copper concentrations appears to be a good indicator of reduced 
weight gain, liver copper concentrations were used to investigation potential associations 
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Figure 4.11 Weight Gain and Liver Copper Accumulation in Individual Birds 
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Figure 4.12 Weight Gain and Feather Copper Accumulation in Individual Birds from the 
14 Day Drinking Water Studies 
250 
4.7.4.1 Clinical Chemistry/ Hematology and Liver Copper 
Regression analysis was used to evaluate the association between clinical chemistry/ 
hematology parameters and liver copper concentrations for individual birds. The 
individuals with extremely elevated liver copper concentrations (Figure 4.5) were 
included in these analyses in spite of the fact that their ability to accumulate copper 
appears to be atypical, because they may provide valuable information about the adverse 
effects associated with biological copper accumulation. Several parameters appear to be 
significantly associated with elevated liver copper concentrations (Table 4.54). Packed 
cell volume (PCV) and total protein concentration had the greatest correlation with liver 
copper concentrations, 0.33 and 0.31 receptively. 
Table 4.54 Associations Between Liver Copper Concentration and Clinical 
Chemistry Parameters 
Parameter Equation Rz p - Value 
PCV y = -0.0021x +37.42 0.33 < 0.001 
Total Protein y = -0.0003x + 3.27 0.31 <0.001 
Globulin y = -0.0002x + 1.66 0.22 <0.001 
Plasma Protein y = -0.0002x + 4.16 0.21 <0.00 1 
Uric Acid y = -0.00lx + 4.22 0.17 <0.001 
Albumin y = -0.00lx + 1.61 0.16 < 0.05 
BUN y = -0.0003x + 1.46 0.09 <0.05 
Glucose y = -0.007x + 221 0.06 <0.05 
Anion Gap y = -0.0007x + 17.6 0.04 < 0.05 
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CHAPTER 5 DISCUSSION 
5.0 Overview 
The studies described m this thesis were conducted as part of a site-specific 
investigation of the Summitville Mine Site. The release of a copper-rich acid mine 
drainage from the Summitville Mine raised concerns about the potential impact to 
waterfowl living on the Alamosa River. A review of the published literature revealed that 
there was a paucity of data on the effects of excess copper in waterfowl. A field survey 
was conducted to determine exposure pathways for resident waterfowl and investigate the 
ecological impact elevated copper concentrations. However, the relatively small size of 
the waterfowl population on the Alamosa River and the lack of information on the effects 
of copper in waterfowl precluded any conclusions regarding the impact of copper on birds 
in the field. 
A laboratory investigation was developed to collect information which could be used 
to support an ecological risk assessment for juvenile waterfowl raised on the Alamosa 
River. There were two goals for the laboratory investigation: 
1) Determine the level of copper exposure that is toxic to juvenile mallards. 
2) Establish methods for evaluating copper exposure in juvenile mallards. 
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5.1 Treatment Effects 
One of the central objectives for this investigation was to characterize the effects of 
copper toxicity in juvenile mallards. Treatment toxicity was evaluated with 
plasma/serum chemistry panels, hematology panels, tissue histopathology, and weight 
gam. 
5. 1. 1 Clinical Chemistry and Hematology 
Clinical chemistry and Hematology panels have been successfully used in a number of 
copper toxicity studies to document a variety of adverse health effects. Examples of 
findings from copper toxicity investigations include: reduced PCV as a marker for copper 
- induced anemia in chickens (Goldberg, 1956), and the measurement of elevated liver 
enzymes in plasma or serum samples in a number of species (Jain, 1993). 
The 250 mg Cu/L pH 5.5 treatment group demonstrated the most significant changes in 
their clinical chemistry parameters (Table 4.28a). Changes in these birds included: 
elevated uric acid, increased potassium, decreased total protein, decreased albumin, and 
decreased globulin. Regression analysis of clinical chemistry/hematology results and 
liver copper concentrations found significant correlations with nine parameters including 
PCV, protein concentrations, and uric acid (Table 4.54). 
Decreased PCV is an important indicator of anemia (Rich, 1995). An investigation of 
copper-induced anemia in chickens found that anemia developed after three to four weeks 
of copper treatment and mortality occurred one to two weeks later (Goldberg, 1956). The 
finding that several mallards with elevated liver copper concentrations had a PCV below 
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30% suggests that these birds may have been experiencing the first signs of copper-
induced anemia. 
Decreased plasma concentrations of albumin can occur when hepatic protein synthesis 
is impaired, but decreased levels of globulin are an indication of protein-losin_g 
enteropathy (Sherding, 1994). Catarrhal gastroenteritis has been reported as a sign of 
copper toxicity in poultry (Aiello, 1998). Copper is reportedly corrosive to the mucous 
membrane of the gastrointestinal tract (Nicholson, 1995), and disruption of the mucosa! 
barrier is one of the leading causes of protein-losing enteropathy (Sherding, 1994). 
Decreased concentrations of albumin, globulin and total proteins were observed in 
mallards with elevated liver copper concentrations, suggesting that the gastrointestinal 
tract was damaged in these birds. Unfortunately, histopathological evaluation was not 
performed on intestinal tissue samples from every treatment groups. However, 
histopathological evaluation of intestinal tissue from a bird with an elevated liver copper 
concentration provided evidence of intestinal tissue damage (Section 5 .1.2). 
Elevated plasma concentrations of uric acid are an indication of renal dysfunction 
(Aiello, 1998). Increased concentrations of plasma potassium can occur with cell 
damage, metabolic acidosis, or acute renal failure (Aiello, 1998). The mallards with 
elevated plasma levels of uric acid and potassium also exhibited elevated kidney copper 
concentrations (Table 4.25) suggesting a possible association between elevated 
concentrations of copper in the kidneys and renal dysfunction. 
Mallards that were exposed to 117 mg CwL at both pH 3.5 and 4.0 had significantly 
elevated plasma bicarbonate and decreased anion gap values (Table 4.38a). Anion gap is 
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calculated as the ratio of sodium and potassium to chloride and bicarbonate (Aiello, 
1998). Plasma bicarbonate concentrations are increased when carbon dioxide levels are 
decreased (Aiello, 1998). The decreased anion gap and increased plasma concentrations 
of bicarbonate are indicative of compensatory alkalosis, a condition that can be trigger~d 
as a compensatory mechanism for acidosis (Aiello, 1998). 
In mammals, ingestion of excess copper commonly produces hepatotoxicity (Demayo, 
1982). No evidence of hepatocyte damage was observed in mallards that demonstrated 
other signs of copper toxicity (i.e., reduced weight gain). Furthermore, no increases in 
the frequency of liver lesions or plasma concentrations of AST were seen in mallards that 
were exposed to the largest non-lethal concentration of copper in drinking water that was 
tested, 250 mg Cu/L. 
The plasma concentrations of AST in both treatment and control groups were 
consistently higher than the reported normal value for mallards (Table 2.3). Plasma 
concentrations of AST can be increased by both hepatic or muscle injury. Increased AST 
due to skeletal muscle injury is associated with increased CK (Johnson, 1994). Plasma 
concentrations of AST and CK were highly correlated (R2 = 0.86), indicating that the 
elevated concentrations of AST may have been due to muscle damage, perhaps a 
consequence of housing conditions, rather than hepatocyte damage. 
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5.1.2 Histopathology 
Histopathology is a standard technique for evaluating the toxic effects of experimental 
treatments. The prevalence and type of lesions found in histology samples can help 
determine target tissues and provide insight about a compound's mechanism of toxicity .. 
An increased frequency of lesions was observed in several treatment groups. Liver 
samples from the high copper treatment group in Study One exhibited microcavitary 
degeneration and other mild hepatocellular changes (Table 4.10). However, similar 
lesions were also observed in the control group. The prevalence of hepatic lesions in both 
treatment and control birds suggests that these changes may have been associated with 
the processes of rearing and handling, and are not associated with treatment. 
Abnormal macrophage pigmentation was observed in 3 of 12 birds (25%) that 
received doses of 330 or 340 mg Cu/kg BW/d (Table 4.30). These treatment groups 
received the highest non-lethal water exposure tested (250 mg Cu/L) (Table 4.52). The 
pigmented cells were identified as lipofuscin- and hemosiderin-type pigmentation. 
Lipofuscin or "aging pigments" are typically found in older animals and are produced by 
the accumulation non-biological material and other cellular debris in the digestive 
vacuoles of phagocytes (Trump, 1980). Sublethal injury to the liver following elevated 
metal exposure could result in the formation of autophagic vacuoles, producing 
lipofuscin-type pigments in juvenile birds. Hemosiderosis is a condition associated with 
increased levels of insoluble iron or other metals in the bloodstream (Trump, 1980). An 
increased frequency of •'iron-containing lipofuscin'' was previously reported in chickens 
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with copper-induced anemia (Goldberg, 1956), and in a group of swans collect from a 
copper contaminated river (Kobayashi, 1992). 
The bird with the hemosiderin-type granules had extremely elevated tissue copper 
concentrations (liver, kidney, and feather) and extremely reduced weight gain. This bil:d 
also had several abnormal plasma chemistry results including decreased glucose, 
increased BUN, increased uric acid, and decreased protein levels (total, albumin, and 
globulin). The other birds with abnormal hepatic pigmentation had significantly elevated 
tissue copper concentrations, and reduced weight gain, but to a lesser extent than other 
birds which did not exhibit hepatic pigmentation. If the hepatic pigments were produced 
by copper treatment, it is not clear why it would be present in some birds that received 
large doses of copper but not in others that received the same treatment. Even if the 
pigments are associated with copper treatment, these tissue changes are not considered as 
evidence of extensive tissue damage (Nordin, 1997). 
A sample of intestinal tissue from one of the mallards that accumulated exceptionally 
large tissue copper concentrations contained deteriorated connective tissue and necrotic 
fat spherules (Section 4.5.4). It has previously been reported that copper is corrosive to 
the gastrointestinal tract (Nicholson, 1995) and the finding of deteriorated intestinal 
connective tissue supports this observation. Unfortunately, samples of intestinal tissue 
for all of the treatment were not submitted for histopathological analysis. 
In Study Six, an increased frequency of hepatocyte vacuolization was observed in birds 
from both the river matrix (4/8), and the 50 mg Cu/L treatment group (3/8) (Table 4.51). 
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However, there was no clear association between these observations and copper 
treatment. 
5.1.3 Weight Gain 
Exposure to elevated copper concentrations in feed and drinking water significantly 
reduced weight gain in 12 treatment groups (Figures 4.1 and 4.2). In every case, 
depressed weight gain occurred without a significant reduction in feed consumption (p > 
0.05) (Tables 4.5, 4.13, 4.22, 4.34, and 4.45). Weight gain was moderately reduced with 
exposures between 70 to 210 mg Cu/kg BW/d. Mallards that received a dose of 250 mg 
Cu/kg BW/d or greater had extremely reduced weight gain. The dramatic decrease in 
weight gain between mallards that received 210 and 250 mg Cu/kg BW/d suggests that 
there is an effect threshold between these two doses. Exposures below the threshold 
appear to produce mild to moderate effects, whereas exposures above the threshold 
substantially reduced weight gain. 
Pullar reported that adult mallards which were exposed to large doses of copper 
experience a significant loss in body weight (1940). Decreased weight gain as a result of 
excess copper ingestion suggests that copper interferes with some essential metabolic 
process. Mallards that were exposed to 340 mg Cu/kg BW/d (250 mg Cu/L at pH 4.5) 
presented signs of protein losing enteropathy (Table 4.28a), indicating that excess copper 
can adversely effect gastrointestinal tissue. Tissue copper accumulation was also reduced 
in mallards that received the largest doses of copper (Figure 4.5) suggesting that copper 
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absorption is decreased when administered in large doses. Large doses of copper may 
interfere with the physiological and biochemical processes of gastrointestinal absorption; 
decreased absorption of feed nutrients would decrease weight gain. 
Weight gain was significantly decreased in mallards that received copper sulfa~e 
treatment when compared birds that received copper acetate treatment (Table 4.53). It is 
possible that the observed reduction in weight gain for the dietary studies may be 
associated with increased sulfate concentrations. However, in the drinking water studies 
reduced weight gain was observed between copper treatment groups with equivalent 
sulfate concentrations (~ 80 - 85 mg/L). If decreased weight gain is associated with 
reduce feed absorption resulting from injury of the gastrointestinal tissue, one possible 
explanation for the absence of reduced weight gain in mallards that were exposed to 
copper acetate is that copper acetate is less caustic to gastrointestinal tissue than copper 
sulfate. 
As a parameter for measuring treatment effects, reduced weight gain demonstrated 
several important qualities including consistency between studies, a clear dose-response 
relationship, and coherence with existing knowledge. However, reduced weight gain 
does have some limitations as an indicator of treatment: reduced weight gain is not a 
biological effect that is specific to copper treatment (i.e., it is affected by other factors), 
and the exact physiological mechanisms responsible for the effect are unknown. 
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5.2 Exposure Assessment 
One the goals of the investigation was to establish a method for evaluating copper 
exposure in juvenile mallards. The concentrations of liver copper, kidney copper, blood 
copper, feather copper, and hepatic metallothionein were evaluated for their ability to 
assess copper exposure in juvenile mallards. 
5.2. 1 Liver Copper 
Liver residue is commonly viewed as a reliable index of exposure for a wide variety of 
contaminants, including copper (Underwood, 1971 ). The pattern of hepatic copper 
accumulation varies among species; liver copper concentration in sheep increase 
proportion to their dietary intake, while rats maintain normal liver copper levels until a 
high dietary level is reached (Underwood, 1971 ). Mallards with minimal copper intake 
appear to sequester substantial concentration of copper in their livers. Prior to this 
investigation it was reported that liver copper concentration in mallards and other ducks 
are typically greater than most avian species (Beck, 1956, and Beck 1962). 
Mallards raised on untreated commercial feed for 34 days accumulated substantial 
concentrations of copper in their livers, up to 700 µg Cu/g DW (Figure 4.4). Commercial 
feeds, like the one used in this study, typically contain copper concentrations greater than 
the recommended dietary level to accelerate weight gain (Cheeke, 1991 ). The basal diet 
contained approximately 25 mg Cu/kg DW (Table 4.3). The recommended dietary level 
for fowl is 9 mg Cu/kg (Cheeke, 1991 ). A comparison of the previously reported liver 
copper data suggests that ducks which are raised in the laboratory on commercial feed 
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have substantially greater hepatic copper concentration when compared to mallards that 
have been collected in the field (Table 2.2). When compared to the diet of wild mallards, 
commercially prepared diets are likely to be relatively rich in copper. Copper 
concentrations in the vegetation samples collected from uncontaminated wetland are~s 
along the Alamosa River (Table 4.1) contained less than half the concentration of copper 
in untreated feed. 
Liver copper concentrations in mallards that received as much as 100 mg Cu/kg BW/d 
were indistinguishable from the liver copper concentrations of untreated birds. The 
absence of elevated hepatic copper concentrations in mallards that received a 4-fold 
increase in exposure suggests that mallards are able to regulate their liver copper levels 
until a threshold concentration is exceeded. Liver copper concentrations were 
significantly increased in mallards that were exposed to 160 mg Cu/kg BW/d or greater 
(Figure 4.5). Hepatic copper concentrations appeared to reach a peak in mallards that 
received 250 mg Cu/kg BW/d; lower liver copper concentrations were seen in mallards 
that received larger doses of copper (Figure 4.5). Extremely large doses of copper (2:: 330 
mg Cu/kg BW/d) may disrupt or saturate the physiological and/or biochemical processes 
of copper absorption. 
There was a significant difference in hepatic copper accumulation between the acetate 
and sulfate treatments which received the same dose of dietary copper (Table 4.53). The 
variation in hepatic copper accumulation between these two forms of copper suggests that 
the biological uptake or bioavailability of copper is dependent on the counter-ion. It has 
previously been reported that several other forms of copper ( copper carbonate, copper 
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oxalate) have increased copper absorption in mammals when compared to copper sulfate 
(Cousins, 1985). The absence of decreased weight gain in the copper acetate treatment 
group (Table 4.12), but increased liver copper concentrations suggest that copper acetate 
is more bioavailable but less toxic than copper sulfate. 
Several birds that received high doses of copper accumulated exceptionally large 
concentrations of copper in their livers(::::: 5749 µg/g OW) (Figure 4.5). These birds may 
have consumed larger quantities of water, or they may have had a predisposition to 
copper accumulation. Ceruloplasmin is an a-globulin that is believed to play an 
important role in regulating tissue copper levels. Excess tissue copper accumulation in 
Wilson's disease has been associated with abnormal expression of ceruloplasmin 
(Chowrimootoo, 1996). The mallards that accumulated extremely large concentrations of 
copper in their livers may have had an impaired capacity to synthesize ceruloplasmin or 
some other copper regulating proteins. 
5.2.2 Kidney Copper 
Compared to liver tissue relatively low levels of copper were found in the kidneys. 
Renal copper concentrations were less 8 µg Cu/g WW for a wide range of copper 
exposures. Significantly increased kidney copper concentrations were only observed in 
mallards that received large doses of copper(::::: 250 mg Cu/kg BW) (Figure 4.6). One of 
the mallards with the exceptionally large hepatic copper concentrations also exhibited the 
highest kidney copper concentrations. No kidney copper results were obtained for the 
114 
other mallard that was considered a high copper accumulator based on liver copper data. 
The relatively low levels of copper that were present in kidneys that suggests that is not a 
primary site of copper deposition. 
5.2.3 Blood Copper 
No increases in blood copper concentrations were observed in mallards that received 
the largest doses copper (340 µg Cu/kg BW/d) (Table 4.24). Even one of the mallards 
that was considered to be high copper accumulators because of its elevated liver and 
kidney copper concentrations, did not have increased levels of copper in its blood (Table 
4.24. In order to minimize analytical costs, and because there were no significant 
differences in the blood copper concentrations between the control groups and the 250 
mg Cu/L treatment groups at pH 4.5 and 5.5, blood copper concentrations were only 
measured in Study Four. 
Increased concentrations of copper in the blood occurs in mammals when the capacity 
for hepatic storage is exceeded (Demayo, 1984 ). The absence of increased copper 
concentrations in the blood of mallards that received as much as 340 mg Cu/kg BW/d 
suggests that this level of exposure is below the dose required to exceed the hepatic 
storage capacity of juvenile mallards. 
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5.2.4 Feather Copper 
Feather copper concentrations were significantly increased at a relatively low dose (:2: 
70 mg Cu/kg BW), when compared to other tissues (Figures 4.7 and 4.8). Because 
feather copper was significantly increased at lower doses than were required to increase 
liver copper concentrations it appears that feather copper accumulation is not subject to 
the same level of physiological regulation as internal tissues and organs. It has 
previously been suggested that metal levels in avian plumage reflect dietary assimilation 
(Rose, 1981 ). 
Feather copper concentrations exposures were significantly correlated with both dietary 
exposure (R2 = 0.86) and drinking water exposures (R2 = 0.76) (Figures 4.7 and 4.8). The 
slopes of the dose response curves for the dietary and drinking water exposures were 
similar for both dietary and drinking water exposures, 0.28 and 0.29 respectively (Section 
4.7.3.3). Feather copper accumulation appears to be a suitable method for assessing 
copper exposure from multiple environmental sources. 
Feather copper concentrations in the highest dose group, 340 mg Cu/g BW, were lower 
than other treatment groups that received smaller doses of copper (Figure 4.8). As 
discussed earlier, a similar pattern was observed in liver copper concentrations. If copper 
accumulation was reduced in liver tissue, but not feather tissue it would suggest that large 
doses of copper interfere with hepatocyte uptake. The hypothesis that ingestion of large 
concentrations copper interfere with intestinal absorption is supported by the finding that 
both feather and liver copper concentration are reduced when exposures exceeded a 
plateau concentration(~ 340 mg Cu/kg BW/d). 
116 
One of the mallards with an unusually large liver copper concentration, 5749 µg Cu/g 
DW, also had the largest feather copper concentration 231 µg Cu/g. However, the 
mallard with the largest liver copper concentration, 9280 µg Cu/g DW, had a relatively 
low concentration of copper in its feather tissue, 53 µg Cu/g. The pre-disposition f9r 
hyper-copper accumulation may be associated with the absence of a biological copper 
ligand that regulates copper distribution. If the protein that normally removes copper 
from the liver is missing, or in limited quantity, accumulation in other depots, like 
feather, may be increased. 
5.2.5 Hepatic Metallothionein 
Concentrations of hepatic metallothionein were analyzed in the pH 4.5 treatment 
groups from Study Four and all of the treatment groups in Study Five. The copper bound 
fraction, and total metallothionein levels were significantly increased (p < 0.001) in 
mallards that received 340 mg Cu/kg BW/d (Table 4.42). The concentrations of copper 
binding protein were not significantly decreased or increased in a mallard that was 
considered to be a high copper accumulator (MT data were only available for one of two 
the high copper accumulators because only the pH 4.5 treatment groups from Study Four 
were analyzed). Regression analysis of individual liver copper concentrations and 
hepatic metallothionein concentrations support the conclusion that the liver copper 
accumulation is not associated with hepatic metallothionein expression. The absence of a 
clear dose-response relationship between copper exposure and metallothionein 
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concentrations in mallards that received large concentrations of copper, as much as 250 
mg Cu/kg BW/d (Table 4.42), suggests that metallothionein synthesis in mallards is not 
significantly induced by copper treatment at or below this level of exposure. 
5.3 Biological Effects of Low pH Drinking Water 
Initially, drinking water pH was investigated for its potential to influence copper 
bioavailability. However, the decreased survival of birds that consumed drinking water at 
pH 3.0 without added copper demonstrated that acidic water can be directly toxic to 
recently hatched mallard ducklings (Table 4.18). In a subsequent study, the toxicity of 
acidic water was confirmed by the reduced weight gain in mallards that consumed 
drinking water at pH 3.5 without added copper (Table 4.33). 
Drinking water with a pH of 3.0 may have produced mortality in young birds because 
their developing systems were not capable of maintaining an acid-base homeostasis. It is 
not clear why mallards would be sensitive to pHs that are easily tolerated by other 
organisms. Mammals can consume solutions with a pH of 2.0 without any adverse 
effects (Lewis, 1987). The observation that acidic water is toxic to juvenile mallards was 
one the most interesting aspects of this investigation. However, because evaluating the 
toxicity of acidic water was not one of the main objectives for the investigation this 
relationship may not have been adequately studied. Further investigations should 
monitor blood gas and blood pH in waterfowl following exposure to acidic water. 
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The influence of pH on copper bioavailability was indirectly assessed by measuring 
tissue copper accumulation in treatment groups that were provided the same 
concentrations of copper at different pH levels. It was anticipated that acidic pH water 
would increase tissue copper accumulation in juvenile mallards, but feather copp~r 
concentrations were reduced rather then increased in treatment groups that received 
highly acidic drinking water (Figure 4.9). It is not clear why tissue copper accumulation 
was reduced in mallards that received low pH copper exposures, but it appears that 
copper absorption is reduced by decreased pH. Decreased copper absorption at low pH 
suggests that ligand-bound copper, rather than free copper, is the predominate mechanism 
for copper uptake (Cousins, 1985). 
5.4 Estimated Copper Doses 
Copper doses were calculated from measured exposure concentrations and mean 
consumption rates (Table 4.52). Mean consumption rates were used to calculate dose 
because feed and water consumption was not measured for individual birds. The mean 
consumption rates were calculated from all treatment to reduce the substantial but not 
statistically significant variation between treatment groups and between studies. 
The mean feed consumption for this investigation, 0.2 gig BW/d, was approximately 
double the previously reported values of feed consumption (Table 2.2). The elevated 
consumption rates in this investigation may be the result of dietary or environmental 
factors associated with the laboratory setting such as temperature or population density. 
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The drinking water consumption rate for this investigation, 1.3 ml/g BW/d, was 
considerably larger than the published estimate of water consumption for mallards (0.06 
gig BW/d); water consumption in the mallard was predicted with an allometric model that 
estimates consumption as a factor of body size and may not properly reflect t~e 
consumption of young birds (EPA, 1983 ). The model for predicting water consumption 
is a generic model for all avian species and may not accurately reflect intake for juvenile 
mallards. Rowe reported a mean water consumption rate of 157 ± 28 g/d in untreated 
adult mallards (1983), which for a 750 g bird would be approximately 0.21 ml/g BW/d. 
The drinking water consumption rate for this investigation maybe greater than the 
previously reported value because factors associated with the animal care such as ambient 
temperature, population density, and diet, or it may reflect differences between juvenile 
and adult birds. 
5.5 Evaluation of Toxicity 
The toxicity of a compound is defined by its dose-response curve, which is described 
with toxicity reference values. There are several common toxicity reference values that 
are derived from the dose-response curve: the No observed Adverse Effect Level 
(NOAEL), the Lowest Observed Adverse Effect Level (LOAEL), and Lethal Dose for 
some percentage of the population (LDx)-
Weight gain was the endpoint that was used to define treatment toxicity. The largest 
dose of dietary copper that did not produce a significant reduction in weight gain, 40 
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mg/kg BW/d is designated as a NOAEL (Table 5.1). The smallest dose to produce a 
significant reduction in weight gain, 90 mg/kg BW/d, is considered a LOAEL. A lethal 
dose of dietary copper sulfate was not established but is in excess of 200 mg Cu/kg 
BW/d. 
The largest dose of copper in drinking water that did not produce a significant 
reduction in weight gain, 20 mg/kg BW/d, is designated as a NOAEL (Table 5.1). The 
smallest dose to produce a significant reduction in weight gain, 60 mg/kg BW/d, is 
considered a LOAEL. A dose of 800 mg/kg BW/d was lethal to more than 50% of the 
population after 96 hours of exposure. An actual LDx value was not calculated because of 
the limited number of observations, but the LD50 would fall within the range of 340 - 800 
mg Cu/kg BW/d. 
The lowest pH that did not produce a significant reduction in weight gain, 4.0, is 
designated as a NOAEL (Table 5.1). The highest pH to produce a significant reduction in 
weight gain, 3.5, is considered a LOAEL. Exposure to pH 3.0 was lethal to more than 
50% of the population after 96 hours of exposure. 
Table 5.1 Toxicity Benchmarks 
Benchmark Dietary Dose Drinking Water Dose pH 
(mg/kg BW/d) (mg/kg BW/d) 
NOAEL 40 20 4.0 
LOAEL 80 60 3.5 
LD>so 800 3.0 
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5.6 Evaluation of Risk to Waterfowl on the Alamosa River 
The purpose of this investigation was to generate data that could be used to assess th.e 
potential impact of environmental copper exposure in waterfowl and collect data that 
could be used to support an ecological risk assessment for the Summitville Mine Site. A 
complete risk assessment for mallards on the Alamosa River is beyond the scope of this 
thesis; however, an interpretation of the laboratory study results with respect to field data 
is certainly warranted. 
Environmental samples collected during the field survey provide an indication of 
potential exposure concentrations along the Alamosa River. Elevated copper 
concentrations were found in water, vegetation, and sediment samples from the Terrace 
Reservoir (Table 4.1). The data from the field survey suggest that the wetland areas, 
which are believed to be the breeding ground for resident waterfowl, may not be 
hydrologically connected to the river. Prior to this study it was assumed that the wetlands 
were fed by Alamosa River water, and would contain elevated copper concentrations. 
The substantially lower copper concentration in the wetland samples suggests that these 
areas may be fed by uncontaminated spring water. 
The largest concentrations of copper in environmental media collected from the 
Alamosa River were found in unwashed vegetation samples. Vegetation typically 
compromises only about 30% of the diet of adults mallards (Eldridge, 1990) and juvenile 
mallards feed almost entirely on invertebrates for the first month of life (Ringelman, 
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1992). Following standard EPA guidance for a baseline risk calculation (EPA, 1989), it 
was assumed 100% of the target receptor's diet is composed of the contaminated media. 
The expected daily intake of copper from unwashed vegetation is 88 mg/kg BW, which 
would produce a hazard quotient (HQ) greater than two (Table 5.2). Copp(l!r 
concentrations in the surface water from the Alamosa River were much lower than the 
copper concentrations in the vegetation samples. The estimated daily dose from drinking 
Alamosa River water contaminated at the level observed in the field study (Table 4.41) is 
0.45 mg/kg BW, which predicts a HQ of 0.02 (Table 5.2). A HQ that exceeds one is 
generally considered to be an indication of an unacceptable risk to a population (EPA, 
1989). 
The increased risk to juvenile mallards from consumption of copper-rich vegetation is 
based on the assumption that the copper in the vegetation has the same bioavailability as 
copper sulfate added to a commercially prepared feed. However, the results of this 
investigation indicate that copper bioavailability varies with the form of copper (Table 
4.53). It is not know if the bioavailability of copper in vegetation would be increased or 
decreased when compared to copper sulfate added to commercial feed. 
Table 5.2 Estimated Risk to Juvenile Mallards on the Alamosa River 
Exposure Source Estimated Daily NOAEL HQ a 
Intake (mg Cu/kg BW/d) 
Vegetation 88 mg/kg BW 40 2.2 
Surface Water 0.45 ml/kg BW 20 0.02 
a HQ = daily intake / NOAEL 
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A dose of 88 mg Cu/kg BW/d was estimated for the consumption of copper - rich 
vegetation. Mallards that received a similar dose of dietary copper in the laboratory 
studies, 90 mg Cu/kg BW, experienced a 10% reduction in weight gain when compared.a 
control group (Figure 5.2). It seems reasonable to assume that juvenile mallards 
consuming vegetation from the Terrace Reservoir would experience a similar decrease in 
weight gain; however, it not known what if, any effect this would have on the population. 
To accurately characterize the impact of copper to waterfowl living along the Alamosa 
River would require a study of reproductive success, which was beyond the scope of this 
project. 
Liver and kidney samples were collected from mallards during the field survey to 
provide a relative assessment of copper exposures for ducks living on the Alamosa River. 
Juvenile mallards collected from contaminated areas of the Alamosa River had 
substantially greater hepatic copper concentrations when compared to birds collected in 
the wetland areas or the Monte Vista NWR (Table 4.2). The increased hepatic copper 
concentrations in the Alamosa River birds indicate that they are exposed to larger 
concentrations of copper. The elevated hepatic copper concentration in mallards from the 
Terrace Reservoir is consistent with increased copper concentrations in the environmental 
samples collected from that area. However, the liver copper concentrations in the 
Alamosa River birds were comparable to the levels found in the control groups from the 
laboratory studies. The estimated dose of copper from the consumption of Alamosa 
River vegetation, 88 mg Cu/kg BW/d, is considerably less than the level of exposure that 
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was found to produce elevated liver copper concentrations (~160 mg Cu/kg BW/d) 
(Figure 4.5). Increased feather copper concentrations are expected from exposure to 
copper at the level which is predicted for mallards that consume aquatic vegetation from 
the Alamosa River, 88 mg Cu/kg BW/d (Figure 4.8). Unfortunately, feather tissue Wi:!S 
not collected during the field survey. Ideally, the field survey should have been 
conducted after the laboratory studies had identified the most appropriate method for 
evaluating copper exposure. In summary, mallards on the Alamosa River appear to have 
increased copper exposure when compared to birds from uncontaminated areas, but the 
magnitude of exposure can not be established from the available information. 
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